Document:

Exhibit 10.1

 

CERTARA, INC.

 

STOCKHOLDERS AGREEMENT

 

Dated as of [●], 2020 

 

     

     

    

 

TABLE OF CONTENTS

 

Page

 

	ARTICLE I DEFINITIONS	1
	1.1   	Certain Matters of Construction	1
	1.2   	Definitions	2
	ARTICLE II COVENANTS AND CONDITIONS	7
	2.1   	Restrictions on Transfers	7
	2.2   	Corporate Governance	8
	2.3   	Confidentiality	9
	ARTICLE III INDEMNIFICATION AND REIMBURSEMENT	10
	3.1   	Indemnification of Institutional Stockholders	10
	3.2   	Reimbursement of Expenses.	12
	ARTICLE IV MISCELLANEOUS	13
	4.1   	Remedies	13
	4.2   	Entire Agreement; Amendment; Waiver	13
	4.3   	Severability	14
	4.4   	Notices	14
	4.5   	Binding Effect; Assignment	15
	4.6   	Governing Law	15
	4.7   	Termination	15
	4.8   	Recapitalizations, Exchanges, Etc.	15
	4.9   	Action Necessary to Effectuate the Agreement	16
	4.10   	Purchase for Investment; Legend on Certificate	16
	4.11   	Effectiveness of Transfers	17
	4.12   	Additional Stockholders	17
	4.13   	Other Business Opportunities	18
	4.14   	No Waiver	19
	4.15   	Costs and Expenses	19
	4.16   	Counterpart	19
	4.17   	Headings	19
	4.18   	Third Party Beneficiaries	19
	4.19   	Consent to Jurisdiction	19
	4.20   	WAIVER OF JURY TRIAL	20
	4.21   	Representations and Warranties	20
	4.22   	Consents, Approvals and Actions	21
	4.23   	No Third Party Liabilities	21

 

    i

     

    

 

	4.24   	Aggregation of Securities	22
	4.25   	Independent Nature of Stockholders’ Obligations and Rights	22
	4.26   	Effectiveness	22

 

EXHIBITS AND ANNEXES 

 

	EXHIBIT A	–	STOCKHOLDER LIST
	Annex I	–	Form of Joinder Agreement
	ANNEX II	–	FORM OF SPOUSAL CONSENT

 

    ii

     

    

 

STOCKHOLDERS AGREEMENT

 

This Stockholders Agreement (as amended, modified
or supplemented from time to time in accordance with its terms, this “Agreement”) of Certara, Inc. (together
with its successors and permitted assigns, the “Company”), a Delaware corporation f/k/a EQT Avatar Topco, Inc.,
is entered into as of [●], 2020, by and among (i) the Company, (ii) the EQT Stockholders (as defined below), (iii) the Arsenal
Stockholders (as defined below), (iv) the Other Institutional Stockholders (as defined below), (v) the Director Stockholders (as
defined below), (vi) the Employee Stockholders (as defined below) and (vii) such other Persons, if any, that from time to time
become parties hereto pursuant to Section 4.12.

 

WHEREAS, in accordance with the terms of the
A&R Limited Partnership Agreement (as defined below), all outstanding interests in the Partnership (as defined below), other
than those interests held by the EQT Stockholders in their capacity as Partners (as defined in the A&R Limited Partnership
Agreement), were exchanged for shares of Common Stock (as defined below);

 

WHEREAS, the Company intends to consummate
an initial Public Offering (as defined below) of shares of Common Stock and enter into the Underwriting Agreement (as defined below)
in connection therewith; and

 

WHEREAS, in connection with such events, the
parties hereto desire to provide for certain governance rights and other matters upon the effectiveness of this Agreement.

 

NOW, THEREFORE, in consideration of the mutual
promises, representations, warranties, covenants and conditions set forth in this Agreement, and other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree, subject to Section 4.26, as follows:

 

ARTICLE
I

DEFINITIONS

 

1.1           Certain
Matters of Construction. In addition to the definitions referred to or set forth below in this
ARTICLE I:

 

(a)               
The words “hereof,” “herein,” “hereunder” and words of similar
import shall, unless the context requires otherwise, refer to this Agreement as a whole and not to any particular Section or provision
of this Agreement, and reference to a particular Section of this Agreement shall include all subsections thereof;

 

(b)               
References to Sections and Articles refer to Sections and Articles of this Agreement;

 

(c)               
Definitions shall be equally applicable to both nouns and verbs and the singular and plural forms of the terms defined;
and

 

(d)               
The masculine, feminine and neuter genders shall each include the others.

 

    1

     

    

 

1.2           Definitions.
For the purposes of this Agreement, the following terms shall have the following meanings:

 

“1933 Act” shall mean the
Securities Act of 1933, as amended, or any successor act, and the rules and regulations promulgated thereunder.

 

“1934 Act” shall mean the
Securities Exchange Act of 1934, as amended, or any successor act, and the rules and regulations promulgated thereunder.

 

“A&R Limited Partnership Agreement”
means the Second Amended and Restated Limited Partnership Agreement of the Partnership, dated as of November 1, 2019, as amended,
restated, supplemented or otherwise modified from time to time, by and among EQT Avatar Parent GP LLC, as general partner, and
the additional parties thereto from time to time.

 

“Action” shall have the
meaning as set forth in Section 3.1(a).

 

“Additional Stockholders”
shall mean, in each case only for so long as such Person or Permitted Transferee is a holder of Shares, (i) any Person who is a
party to this Agreement (whether through execution of this Agreement or a Joinder Agreement) other than the Company and its Subsidiaries,
the Institutional Stockholders and the Individual Stockholders and (ii) such Persons’ Permitted Transferees pursuant to the
definition of Permitted Transfer (other than the Company), as evidenced by an executed Joinder Agreement, indicating that such
Permitted Transferee will be an Additional Stockholder.

 

“Affiliate” shall mean,
with respect to any specified Person, any other Person which, directly or indirectly, through one or more intermediaries controls,
or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control”
(including, with correlative meanings, the terms “controlling,” “controlled by” and “under
common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power
to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities,
by agreement or otherwise); provided, however, that, for purposes of this Agreement, (i) the Company and its Subsidiaries
shall not be an Affiliate of any Stockholder or such Stockholder’s Affiliates and (ii) none of the EQT Stockholders shall
be considered Affiliates of any portfolio company in which (x) the EQT Stockholders or (y) any investment funds, vehicles and accounts
affiliated with, or advised, managed or sponsored by the EQT Stockholders or their Affiliates have made a debt or equity investment
(and vice versa).

 

“Agreement” shall have
the meaning set forth in the first paragraph of this Agreement.

 

“Applicable Individual”
shall mean (i) with respect to any Individual Stockholder who is a director, employee, consultant or other service provider of
the Company or any of its Subsidiaries, such director, employee, consultant or other service provider and (ii) with respect to
any Individual Stockholder who is not a director, employee, consultant or other service provider of the Company or any of its Subsidiaries,
the director, employee, consultant or other service provider of the Company or any of its Subsidiaries with respect to whom such
Individual Stockholder is a Permitted Transferee.

 

“Arsenal Consent” shall
mean the prior written consent of the Arsenal Stockholders holding a majority of the Shares held by the Arsenal Stockholders.

 

“Arsenal Director Nominee”
shall have the meaning as set forth in Section 2.2(a)(i)(A).

 

“Arsenal
Stockholders” shall mean, in each case only for so long as such Person or Permitted Transferee is a holder of
Shares, (i) those Persons who are listed as Arsenal Stockholders on Exhibit A hereto and (ii) their respective
Permitted Transferees pursuant to the definition of Permitted Transfer (other than the Company), as evidenced by an executed
Joinder Agreement indicating that such Permitted Transferee will be an Arsenal Stockholder.

 

    2

     

    

 

“Board” or “Board
of Directors” shall mean the Board of Directors of the Company as the same shall be constituted from time to time.

 

“Common Stock” shall mean
the Company’s common stock, par value $0.001 per share, and shall also include any common stock of the Company hereafter
authorized and any capital stock of the Company of any other class hereafter authorized which does not have a preference as to
dividends or distribution of assets in liquidation over any other class of capital stock of the Company.

 

“Company” shall have the
meaning set forth in the first paragraph of this Agreement.

 

“Controlled Entity” shall
mean any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise
controlled by the Company.

 

“Director Stockholders”
shall mean, in each case only for so long as such Person or Permitted Transferee is a holder of Shares, (i) those Persons who are
listed as Director Stockholders on Exhibit A hereto and (ii) their respective Permitted Transferees (other than the Company)
who receive Shares from such Person pursuant to a Permitted Transfer as evidenced by an executed Joinder Agreement indicating that
such Permitted Transferee will be a Director Stockholder.

 

“Employee Stockholders”
shall mean, in each case only for so long as such Person or Permitted Transferee is a holder of Shares, (i) those Persons who are
listed as Employee Stockholders on Exhibit A hereto, (ii) any other Person who acquires Shares pursuant to the exercise
of Options and provides an executed Joinder Agreement, indicating that such Person will be an Employee Stockholder and (iii) their
respective Permitted Transferees (other than the Company) who receive Shares from such Person pursuant to a Permitted Transfer
as evidenced by an executed Joinder Agreement indicating that such Permitted Transferee will be an Employee Stockholder.

 

“EQT Consent” shall mean
the prior written consent of the EQT Stockholders holding a majority of the Shares held by the EQT Stockholders.

 

“EQT Director Nominee”
shall have the meaning as set forth in Section 2.2(a)(i)(B).

 

“EQT Stockholders” shall
mean, in each case only for so long as such Person or Permitted Transferee is a holder of Shares, (i) those Persons who are listed
as EQT Stockholders on Exhibit A hereto and (ii) their respective Permitted Transferees (other than the Company) who receive
Shares from such Person pursuant to a Permitted Transfer as evidenced by an executed Joinder Agreement indicating that such Permitted
Transferee will be an EQT Stockholder.

 

“Incentive Plan” shall
mean the Certara, Inc. 2020 Equity Incentive Plan, as amended from time to time, together with any other compensatory stock plan
adopted by the Company, as amended from time to time.

 

“Indemnification Sources”
shall have the meaning as set forth in Section 3.1(c).

 

“Indemnified Liabilities”
shall have the meaning as set forth in Section 3.1(a).

 

“Indemnitees” shall have
the meaning as set forth in Section 3.1(a).

 

    3

     

    

 

“Individual Stockholders”
shall mean the Director Stockholders and the Employee Stockholders.

 

“Institutional Stockholders”
shall mean the EQT Stockholders, the Arsenal Stockholders and the Other Institutional Stockholders.

 

“Joinder Agreement” means
a joinder agreement substantially in the form of Annex I attached hereto or such other form as may be agreed by the Company.

 

“Jointly Indemnifiable Claims”
shall have the meaning as set forth in Section 3.1(c).

 

“Law” shall have the meaning
as set forth in Section 2.3.

 

“Non-EQT Institutional Stockholders”
shall mean the Institutional Stockholders other than the EQT Stockholders.

 

“Non-Institutional Stockholders”
shall mean the Stockholders other than the Institutional Stockholders.

 

“Options” shall mean the
options granted to certain Individual Stockholders under the Incentive Plan to purchase Shares on the terms set forth therein and
in the certificates and agreements issued pursuant thereto.

 

“Other Institutional Stockholders”
shall mean, in each case only for so long as such Person or Permitted Transferee is a holder of Shares, (i) those Persons who are
listed as Other Institutional Stockholders on Exhibit A hereto and (ii) their respective Permitted Transferees (other than
the Company) who receive Shares from such Person pursuant to a Permitted Transfer as evidenced by an executed Joinder Agreement
indicating that such Permitted Transferee will be an Other Institutional Stockholder.

 

“Partnership” means EQT
Avatar Parent L.P., a Delaware limited partnership, and any successors and assigns thereof.

 

“Permitted Transfer” shall
mean:

 

(i)                
a Transfer of Shares by any Stockholder who is a natural person (or a trustee of a trust for
the benefit of a natural person) or any Individual Stockholder to (a) such Stockholder’s (or, in the case of an Individual
Stockholder, such Individual Stockholders’ Applicable Individual’s) spouse, children (including legally adopted children
and stepchildren), spouses of children, grandchildren (including legally adopted children or stepchildren of such Stockholder’s
children), spouses of grandchildren, parents or siblings; (b) a trustee of a trust for the benefit of such Stockholder (or, in
the case of an Individual Stockholder, the Applicable Individual of such Individual Stockholder) and/or any of the Persons described
in clause (a); or (c) a corporation, limited partnership or limited liability company whose sole shareholders, partners or members,
as the case may be, are such Stockholder (or, in the case of an Individual Stockholder, the Applicable Individual of such Individual
Stockholder) and/or any of the Persons described in clause (a) or clause (b).

 

(ii)             
a Transfer of Shares by any Stockholder to the Company (including, without limitation, any
pledge of Shares or Options to the Company);

 

    4

     

    

 

(iii)           
 a Transfer of Shares by a Stockholder who is a natural person upon death or incapacity to
such Stockholder’s estate, executors, trustees, administrators and personal representatives, and then to such Stockholder’s
legal representatives, heirs, beneficiaries or legatees (whether or not such recipients are a spouse, children, spouses of children,
grandchildren, spouses of grandchildren, parents or siblings of such Stockholder);

 

(iv)            
a Transfer of Shares by any EQT Stockholder to (a) any Affiliate of such EQT Stockholder,
(b) any investment fund or alternative investment vehicle, directly or indirectly, affiliated with, or managed or sponsored by,
such EQT Stockholder or (c) any of the partners, members or Affiliates of such EQT Stockholder or any of the foregoing;

 

(v)              
a Transfer of Shares by any Arsenal Stockholder to (a) any Affiliate of such Arsenal Stockholder,
(b) any investment fund or alternative investment vehicle, directly or indirectly, affiliated with, or managed or sponsored by,
such Arsenal Stockholder or (c) any of the partners, members or Affiliates of such Arsenal Stockholder or any of the foregoing;

 

(vi)            
a Transfer of Shares by any Institutional Stockholder (other than the EQT Stockholders and
the Arsenal Stockholders) to any Affiliate of such Institutional Stockholder; and

 

(vii)         
a Transfer of Shares by any Additional Stockholder who is not a natural person to any Affiliate
of such Additional Stockholder;

 

provided, however, that, notwithstanding anything
herein to the contrary, Options may only be transferred in accordance with the terms of the Incentive Plan; provided, further,
that no Permitted Transfer shall be effective unless and until the transferee of the Shares so transferred executes and delivers
to the Company a Joinder Agreement and agrees to be bound hereunder in the same manner and to the same extent as the Stockholder
from whom the Shares were transferred as provided for in Section 4.12. On subsequent transfers by a Permitted Transferee,
the determination of whether the transferee is a Permitted Transferee shall be determined by reference to the Stockholder who was
an original party to this Agreement, not by reference to the transferring Permitted Transferee in such subsequent transfer. If
at any time after a Permitted Transfer, a transferee ceases to be a Permitted Transferee of the Stockholder who transferred the
Shares to the transferee, then such transferee must transfer the Shares to such original Stockholder or a Permitted Transferee
of such original Stockholder as promptly as practicable. No Permitted Transfer shall conflict with or result in any violation of
a judgment, order, decree, statute, law, ordinance, rule or regulation.

 

“Permitted Transferee”
shall mean any Person who shall have acquired and who shall hold Shares or Options pursuant to a Permitted Transfer.

 

“Person” shall mean any
individual, partnership, corporation, association, limited liability company, trust, joint venture, unincorporated organization
or entity, or any government, governmental department or agency or political subdivision thereof.

 

“Proprietary Information”
shall have the meaning as set forth in Section 2.3.

 

“Public Offering” shall
mean the completion of a sale of Common Stock pursuant to a registration statement which has become effective under the 1933 Act
(excluding registration statements on Form S-4, S-8 or similar limited purpose forms), in which some or all of the Common Stock
shall be listed and traded on a national exchange or on the NASDAQ National Market System.

 

    5

     

    

 

“register”, “registered”
and “registration” shall mean a registration effected pursuant to a registration statement filed with the SEC
(a “Registration Statement”) in compliance with the 1933 Act.

 

“Registration Rights Agreement”
shall mean the Amended and Restated Registration Rights Agreement of the Company, by and among the Company, the EQT Stockholders,
the Arsenal Stockholders and the other parties thereto, dated as of the date hereof, as amended, restated, supplemented or otherwise
modified from time to time.

 

“Rule 144” means Rule 144
(or any successor provision) under the 1933 Act, as such provision is amended from time to time.

 

“SEC” shall mean the United
States Securities and Exchange Commission.

 

“Shares” shall mean (i)
shares of Common Stock held by Stockholders from time to time, including upon exercise of any Options, (ii) other equity securities
of the Company or its Subsidiaries held by the Stockholders or (iii) securities of the Company or its Subsidiaries issued in exchange
for, upon reclassification of, or as a dividend or distribution in respect of, the foregoing; provided, that, notwithstanding
anything herein to the contrary, for purposes of Sections 2.2, 4.2 and 4.21, the term “Shares” shall
only include (x) shares of Common Stock and (y) shares of Common Stock issuable upon exercise of Options (solely to the extent
such Options, on or prior to the time the determination of Shares is made, are vested and, if such Options may be exercised on
a “net exercise” basis in accordance with their terms, as determined after giving effect to the net exercise thereof
as of such time of determination), in each case, held by the applicable Stockholder.

 

“Spousal Consent” shall
have the meaning as set forth in Section 4.21(d).

 

“Stockholder Nominee” shall
have the meaning as set forth in Section 2.2(a)(i)(B).

 

“Stockholders” shall mean
the Institutional Stockholders, the Individual Stockholders and the Additional Stockholders.

 

“Subsidiary” with respect
to any entity (the “parent”) shall mean any corporation, limited liability company, company, firm, association
or trust of which such parent, at the time in respect of which such term is used, (i) owns directly or indirectly more than fifty
percent (50%) of the equity, membership interest or beneficial interest, on a consolidated basis, or (ii) owns directly or controls
with power to vote, directly or indirectly through one or more Subsidiaries, shares of the equity, membership interest or beneficial
interest having the power to elect more than fifty percent (50%) of the directors, trustees, managers or other officials having
powers analogous to that of directors of a corporation. Unless otherwise specifically indicated, when used herein the term Subsidiary
shall refer to a direct or indirect Subsidiary of the Company.

 

“Transfer” and “Transferred”
shall mean to transfer, sell, assign, pledge, hypothecate, give, create a security interest in or lien on, place in trust (voting
or otherwise), assign or in any other way encumber or dispose of, directly or indirectly, and whether or not by operation of law
or for value, any Shares or Options or any legal, economic or beneficial interest therein; provided, however, that
(i) a transfer of limited partnership interests, limited liability company interests or similar interests in any of the EQT Stockholders,
any other private equity fund or any parent entity or investment holding vehicle with respect to any such EQT Stockholder or private
equity fund and (ii) a transfer pursuant to a pledge, lien or other security interest securing any current, former or future indebtedness
incurred by the Company or any of its Subsidiaries in favor of any lender or other holder of such indebtedness, in each case, shall
not constitute a Transfer for purposes of this Agreement.

 

    6

     

    

 

“Underwriting Agreement”
shall mean an underwriting agreement among the Company, Jefferies LLC, Morgan Stanley & Co. LLC and the other investment banks
party thereto with respect to an underwritten initial Public Offering.

 

ARTICLE
II

COVENANTS AND CONDITIONS

 

Subject to the provisions of Section 4.7
hereof relating to the termination of certain provisions of this Agreement, the following covenants and conditions shall apply.

 

2.1           Restrictions on Transfers.

 

(a)               
General Transfer Restrictions. Each Stockholder hereby agrees with the Company, severally and not jointly, that until
the twelve (12)-month anniversary of an initial Public Offering (subject to any applicable lock-up periods agreed with the underwriters
with respect thereto), without the prior consent of the Board, no Stockholder (other than any of the EQT Stockholders) may Transfer
all or any of the Shares owned by such Stockholder to any Person other than (i) to a Permitted Transferee or (ii) solely in the
case of the Employee Stockholders or Director Stockholders, pursuant to any purchase by the Company or any of its Subsidiaries
from an Employee Stockholder or Director Stockholder upon termination of employment of the Applicable Individual with respect to
such Employee Stockholder or the cessation of membership on the Board by such Director Stockholder, as the case may be, (iii) pursuant
to the exercise of registration rights pursuant to and in accordance with the Registration Rights Agreement or (iv) pursuant to
the Underwriting Agreement. Notwithstanding anything herein to the contrary, Options shall only be transferable according to their
terms and the terms of the Incentive Plan. Any attempted Transfer of Shares by a Stockholder not permitted by this Section 2.1
shall be null and void, and the Company shall not in any way give effect to such impermissible Transfer. For the avoidance of doubt,
each of the EQT Stockholders may Transfer all or any portion of its Shares at any time without restriction under this Section
2.1. After the twelve (12)-month anniversary of the consummation of an initial Public Offering (subject to any applicable lock-up
periods agreed with the underwriters with respect thereto), there shall be no restrictions on a Transfer of Shares pursuant to
this Agreement.

 

(b)               
Transferred Shares Subject to Transfer Restrictions. Except for Transfers (i) to the Company, (ii) pursuant to an
effective Registration Statement filed with the SEC, (iii) with the prior consent of the Board or (iv) by any of the EQT Stockholders,
any Shares Transferred by a Stockholder pursuant to this Section 2.1 prior to the twelve (12)-month anniversary of the consummation
of an initial Public Offering (subject to any applicable lock-up periods agreed with the underwriters with respect thereto) shall
remain subject to the Transfer restrictions of this Agreement and each intended transferee pursuant to this Section 2.1
shall execute and deliver to the Company a Joinder Agreement, which shall evidence such transferee’s agreement that the Shares
intended to be transferred shall continue to be subject to this Agreement and that as to such Shares the transferee shall be bound
by the restrictions of this Agreement as a Stockholder hereunder.

 

    7

     

    

 

2.2           Corporate Governance.

 

(a)               
Board of Directors. The Company hereby agrees that:

 

(i)                
 Unless otherwise agreed in writing by the EQT Stockholders (and, in the case of (x) the right to nominate the Arsenal Director
Nominee pursuant to Section 2.2(a)(i)(A) and (y) Section 2.2(a)(ii) as it relates to the Arsenal Director Nominee,
the Arsenal Stockholders), and subject to applicable law (including laws relating to fiduciary duties) and the rules and regulations
of the applicable stock exchange:

 

(A)             
for so long as the Company’s certificate of incorporation shall provide for the division of directors into three (3)
classes, the Company shall nominate to serve on the Board of Directors as a Class II director (or, with the approval of the Board
of Directors, such other class of directors as the Arsenal Stockholders shall designate) one (1) individual designated by the Arsenal
Stockholders holding a majority of the aggregate Shares then held by the Arsenal Stockholders for so long as the Arsenal Stockholders
collectively hold at least five percent (5%) of the Shares as part of any slate that is included in the proxy statement (or consent
solicitation or similar document) of the Company relating to the election of Class II directors; provided, that such individual
shall be an investment professional employed by an Arsenal Stockholder or one of its Affiliates or another individual with EQT
Consent. In the event the Company’s certificate of incorporation shall not provide for the division of directors into three
(3) classes, the Company shall nominate to serve on the Board of Directors one (1) individual designated by the Arsenal Stockholders
holding a majority of the aggregate Shares then held by the Arsenal Stockholders for so long as the Arsenal Stockholders collectively
hold at least five percent (5%) of the Shares as part of any slate that is included in the proxy statement (or consent solicitation
or similar document) of the Company relating to the election of directors; provided, that such individual shall be an investment
professional employed by an Arsenal Stockholder or one of its Affiliates or another individual with EQT Consent (the individual,
if any, nominated pursuant to this Section 2.2(a)(i)(A), the “Arsenal Director Nominee”). For so long
as the directors on the Board of Directors are divided into three (3) classes, the Arsenal Director Nominee shall be a Class II
director; and

 

(B)             
the Company shall nominate to serve on the Board of Directors a number of individuals designated by the EQT Stockholders
such that, upon the election of all such individuals and taking into account any director continuing to serve on the Board of Directors
without need for re-election who was designated by the EQT Stockholders pursuant to this Section 2.2(a)(i)(B), the total
number of directors designated by the EQT Stockholders shall equal (x) the total members of the Board of Directors, multiplied
by (y) the percentage of Shares held from time to time by the EQT Stockholders, which number shall be rounded up to the next highest
whole number of directors (the “EQT Director Nominees” and, together with the Arsenal Director Nominee, the
 “Stockholder Nominees”); provided that in no event shall the number of EQT Director Nominees, together
with the Arsenal Director Nominee, if any, exceed the number of directors permitted by the Company’s certificate of incorporation
or bylaws; and further provided that the right of the EQT Stockholders to designate one or more individuals for nomination
pursuant to this Section 2.2(a)(i)(B) shall terminate if the EQT Stockholders collectively hold less than five percent (5%)
of the Shares.

 

    8

     

    

 

(ii)               The
Company shall include as part of the slate that is included in the proxy statement (or consent solicitation or similar
document) of the Company relating to the election of directors to the Board of Directors, (x) the Arsenal Director Nominee
designated for nomination pursuant to Section 2.2(a)(i)(A) (if such proxy statement (or consent solicitation or
similar document) relates to the election of Class II directors) and (y) the EQT Director Nominees (if such proxy statement
(or consent solicitation or similar document) relates to the election of directors of the class or classes to which EQT
Director Nominees belong pursuant to Section 2.2(a)(i)(B)) and shall provide the highest level of support for the
election of each person nominated pursuant to Section 2.2(a)(i) as it provides to any other individual standing for
election as a director of the Company as part of such Company slate of directors.

 

(iii)            
In the event that a Stockholder Nominee shall cease to serve as a director for any reason (other than the failure of the
stockholders of the Company to elect such individual as a director), the Persons entitled to designate such Stockholder Nominee
pursuant to Section 2.2(a)(i)(A) or (B) shall have the right to designate a replacement Stockholder Nominee and the
Company agrees to appoint any such replacement Stockholder Nominee to fill the vacancy resulting therefrom. For the avoidance of
doubt, it is understood that the failure of the stockholders of the Company to elect any Stockholder Nominee shall not affect the
right of the Persons entitled to designate such Stockholder Nominee pursuant to Section 2.2(a)(i)(A) or (B) to designate
a Stockholder Nominee for election pursuant to Section 2.2(a)(i)(A) or (B) in connection with any future election
of directors of the Company.

 

(iv)             
Upon the classification of the Board of Directors into three (3) classes, the initial Arsenal Director Nominee shall be
Stephen M. McLean and the initial EQT Director Nominees shall be Eric C. Liu, Ethan Waxman and Sherilyn S. McCoy. Upon the classification
of the Board of Directors into three (3) classes, the initial Class I directors shall consist of Mason P. Slaine, James E. Cashman
III and Ethan Waxman, the initial Class II directors shall consist of Sherilyn S. McCoy, Eric C. Liu and Matthew Walsh, and the
initial Class III directors shall consist of Stephen M. McLean and William F. Feehery.

 

(b)               
Each Stockholder hereby agrees with the Company, severally and not jointly, that for so long as any Stockholder is entitled
to designate a Stockholder Nominee pursuant to Section 2.2(a)(i), such Stockholder shall vote all of its Shares in favor
of each individual standing for election as a director of the Company as part of the Company’s slate of directors that is
included in the proxy statement (or consent solicitation or similar document) of the Company relating to the election of directors
to the Board of Directors and whose election the Board of Directors has recommended.

 

(c)               
The right to nominate the Arsenal Director Nominee pursuant to Section 2.2(a)(i)(A) may not be assigned or otherwise
conveyed by any Arsenal Stockholder other than (i) to its Permitted Transferees or (ii) with EQT Consent.

 

2.3           Confidentiality.
Each Stockholder shall maintain the confidentiality of any confidential and proprietary information of the Company and its
Subsidiaries (“Proprietary Information”) using the same standard of care, but in no event less than
reasonable care, as it applies to its own confidential information, except (i) for any Proprietary Information which is
publicly available (other than as a result of dissemination by such Stockholder in breach of this Agreement) or a matter of
public knowledge generally, (ii) if the release of such Proprietary Information is ordered pursuant to a subpoena or other
order from a court of competent jurisdiction or other applicable law, rule, regulation, legal or judicial process or audit or
inquiries by a regulator, bank examiner or self-regulatory organization (collectively, “Law”), following
delivery of prior written notice to the Company (to the extent reasonably practicable and permitted under applicable Law),
(iii) for Proprietary Information that was known to such Stockholder on a non-confidential basis, without, to such
Stockholders’ knowledge, breach of any confidentiality obligations to the Company or its Affiliates in respect thereof,
prior to its disclosure by the Company or its Affiliates or (iv) as concerns the EQT Stockholders, for disclosure to EQT
Partners AB (and its subsidiaries), any EQT branded funds and their respective directors, officers and employees.

 

    9

     

    

 

ARTICLE
III

INDEMNIFICATION AND REIMBURSEMENT

 

3.1           Indemnification of Institutional Stockholders.

 

(a)               
The Company will, and will cause its Subsidiaries to, jointly and severally, indemnify, exonerate and hold the Institutional
Stockholders and each of their respective partners, stockholders, members, Affiliates, directors, officers, fiduciaries, managers,
controlling Persons, employees and agents and each of the partners, stockholders, members, Affiliates, directors, officers, fiduciaries,
managers, controlling Persons, employees and agents of each of the foregoing (collectively, the “Indemnitees”)
free and harmless from and against any and all liabilities, losses, damages and costs and out-of-pocket expenses in connection
therewith (including reasonable attorneys’ fees and expenses) incurred by the Indemnitees or any of them before or after
the date of this Agreement (collectively, the “Indemnified Liabilities”), arising out of any action, cause of
action, suit, litigation, investigation, inquiry, arbitration or claim (each, an “Action”) arising directly
or indirectly out of, or in any way relating to, (i) such Institutional Stockholder’s or its Affiliates’ ownership
of Shares or such Institutional Stockholder’s or its Affiliates’ control or ability to influence the Company or any
of its Subsidiaries (other than any such Indemnified Liabilities (x) to the extent such Indemnified Liabilities arise out of any
breach of this Agreement, any other agreement by such Indemnitee or its Affiliates or other related Persons or the breach of any
fiduciary or other duty or obligation of such Indemnitee to its direct or indirect equity holders, creditors or Affiliates or (y)
to the extent such control or the ability to control the Company or any of its Subsidiaries derives from such Stockholder’s
or its Affiliates’ capacity as an officer or director of the Company or any of its Subsidiaries) or (ii) the business, operations,
properties, assets or other rights or liabilities of the Company or any of its Subsidiaries; provided, however, that,
if and to the extent that the foregoing undertaking may be unavailable or unenforceable for any reason, the Company will, and will
cause its Subsidiaries to, jointly and severally make the maximum contribution to the payment and satisfaction of each of the Indemnified
Liabilities that is permissible under applicable law. For the purposes of this Section 3.1, none of the circumstances described
in the limitations contained in the immediately preceding sentence shall be deemed to apply absent a final non-appealable judgment
of a court of competent jurisdiction to such effect, in which case to the extent any such limitation is so determined to apply
to any Indemnitee as to any previously advanced indemnity payments made by the Company, then such payments shall be promptly repaid
by such Indemnitee to the Company.

 

(b)                The
Company will, and will cause its Subsidiaries to, jointly and severally, reimburse any Indemnitee for all reasonable costs
and expenses (including reasonable attorneys’ fees and expenses and any other litigation-related expenses) as they are
incurred in connection with investigating, preparing, pursuing, defending or assisting in the defense of any Action for which
the Indemnitee would be entitled to indemnification under the terms of this ARTICLE III, or any action or proceeding
arising therefrom, whether or not such Indemnitee is a party thereto. The Company and its Subsidiaries, in the defense of any
Action for which an Indemnitee would be entitled to indemnification under the terms of this ARTICLE
III, may, without the consent of such Indemnitee, consent to entry of any judgment or enter into any settlement if and
only if it (i) includes as a term thereof the giving by the claimant or plaintiff therein to such Indemnitee of an
unconditional release from all liability with respect to such Action, (ii) does not impose any limitations (equitable or
otherwise) on such Indemnitee and (iii) does not include a statement as to or an admission of fault, culpability or a
failure to act by or on behalf of such Indemnitee, and provided that the only penalty imposed in connection with such
settlement is a monetary payment that will be paid in full by the Company or its Subsidiaries.

 

    10

     

    

 

(c)                The
Company acknowledges and agrees that it shall, and to the extent applicable shall cause the Controlled Entities to, be fully
and primarily responsible for the payment to the Indemnitee in respect of Indemnified Liabilities in connection with any
Jointly Indemnifiable Claims (as defined below), pursuant to and in accordance with (as applicable) the terms of (i) the
Delaware General Corporation Law, as amended, (ii) the certificate of incorporation or similar organizational documents, as
amended, of the Company, (iii) the bylaws or similar organizational documents, as amended, of the Company, (iv) any director
or officer indemnification agreement, (v) this Agreement, (vi) any other agreement between the Company or any Controlled
Entity and the Indemnitee pursuant to which the Indemnitee is indemnified, (vii) the laws of the jurisdiction of
incorporation or organization of any Controlled Entity and/or (viii) the certificate of incorporation, certificate of
organization, bylaws, partnership agreement, operating agreement, certificate of formation, certificate of limited
partnership or other organizational or governing documents of any Controlled Entity (clauses (i) through (viii),
collectively, the “Indemnification Sources”), irrespective of any right of recovery the Indemnitee may
have from any corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other
enterprise (other than the Company, any Controlled Entity or the insurer under and pursuant to an insurance policy of the
Company or any Controlled Entity) from whom an Indemnitee may be entitled to indemnification with respect to which, in whole
or in part, the Company or any Controlled Entity may also have an indemnification obligation (collectively, the
 “Indemnitee-Related Entities”). Under no circumstance shall the Company or any Controlled Entity be
entitled to any right of subrogation or contribution by the Indemnitee-Related Entities and no right of advancement or
recovery the Indemnitee may have from the Indemnitee-Related Entities shall reduce or otherwise alter the rights of the
Indemnitee or the obligations of the Company or any Controlled Entity under the Indemnification Sources. In the event that
any of the Indemnitee-Related Entities shall make any payment to the Indemnitee in respect of indemnification with respect to
any Jointly Indemnifiable Claim, (x) the Company shall, and to the extent applicable shall cause the Controlled Entities to,
reimburse the Indemnitee-Related Entity making such payment to the extent of such payment promptly upon written demand from
such Indemnitee-Related Entity, (y) to the extent not previously and fully reimbursed by the Company and/or any Controlled
Entity pursuant to clause (x), the Indemnitee-Related Entity making such payment shall be subrogated to the extent of the
outstanding balance of such payment to all of the rights of recovery of the Indemnitee against the Company and/or any
Controlled Entity, as applicable, and (z) Indemnitee shall execute all papers reasonably required and shall do all things
that may be reasonably necessary to secure such rights, including the execution of such documents as may be necessary to
enable the Indemnitee-Related Entities effectively to bring suit to enforce such rights. The Company and Indemnitees agree
that each of the Indemnitee-Related Entities shall be third-party beneficiaries with respect to this Section 3.1(c),
entitled to enforce this Section 3.1(c) as though each such Indemnitee-Related Entity were a party to this Agreement.
The Company shall cause each of the Controlled Entities to perform the terms and obligations of this Section 3.1(c) as
though each such Controlled Entity was a party to this Agreement. For purposes of this Section 3.1(c), the term
 “Jointly Indemnifiable Claims” shall be broadly construed and shall include, without limitation, any
Indemnified Liabilities for which the Indemnitee shall be entitled to indemnification from both (1) the Company and/or any
Controlled Entity pursuant to the Indemnification Sources, on the one hand, and (2) any Indemnitee-Related Entity pursuant to
any other agreement between any Indemnitee-Related Entity and the Indemnitee pursuant to which the Indemnitee is indemnified,
the laws of the jurisdiction of incorporation or organization of any Indemnitee-Related Entity and/or the certificate of
incorporation, certificate of organization, bylaws, partnership agreement, operating agreement, certificate of formation,
certificate of limited partnership or other organizational or governing documents of any Indemnitee-Related Entity, on the
other hand.

 

    11

     

    

 

(d)               
The rights of any Indemnitee to indemnification pursuant to this Section 3.1 will be in addition to any other rights
any such Person may have under any other Section of this Agreement or any other agreement or instrument to which such Indemnitee
is or becomes a party or is or otherwise becomes a beneficiary or under law or regulation or under the certificate of incorporation
or bylaws of the Company, any newly formed direct or indirect parent or any direct or indirect Subsidiary or investment holding
vehicle with respect to any of the foregoing.

 

(e)               
The Company shall obtain and maintain in effect at all times directors’ and officers’ liability insurance that,
for so long as the EQT Stockholders are entitled to designate any EQT Director Nominee pursuant to Section 2.2(a)(i)(B),
is reasonably satisfactory to the EQT Stockholders.

 

3.2           Reimbursement of Expenses.

 

(a)               
The Company will pay directly or reimburse, or cause to be paid directly or reimbursed, the actual and reasonable out-of-pocket
costs and expenses incurred by the EQT Stockholders and their respective Affiliates in connection with the monitoring and/or overseeing
of their investment in the Company, including (i) reasonable out-of-pocket expenses incurred by the EQT Director Nominees in connection
with such EQT Director Nominees’ board service (including travel), (ii) fees and actual and reasonable out-of-pocket disbursements
of any independent professionals and organizations, including independent accountants, outside legal counsel or consultants retained
by such EQT Stockholders or any of their Affiliates, (iii) reasonable costs of any outside services or independent contractors
such as financial printers, couriers, business publications, on-line financial services or similar services, retained or used by
such EQT Stockholders or any of their respective Affiliates and (iv) transportation, word processing expenses or any similar expense
not associated with their or their Affiliates’ ordinary operations; provided, that, with respect to clauses (ii) through
(iv) above, any such costs or expenses shall not exceed $120,000 in the aggregate in any single fiscal year (exclusive of any costs
or expenses paid pursuant to clause (i) above) and further provided, that the right of the EQT Stockholders to reimbursement
pursuant to clauses (ii) though (iv) above shall terminate if the EQT Stockholders collectively hold less than five percent (5%)
of the Shares.

 

(b)               
The Company will pay directly or reimburse, or cause to be paid directly or reimbursed, the actual and reasonable out-of-pocket
costs and expenses incurred by the Arsenal Director Nominees hereunder in connection with such Arsenal Director Nominees’
board service (including travel).

 

(c)                All
payments or reimbursement for such costs and expenses pursuant to this Section 3.2 will be made by wire transfer in
same-day funds to the bank account designated by such EQT Stockholder or its relevant Affiliate or such Arsenal Director
Nominee promptly upon or as soon as practicable following request for reimbursement; provided, however,
that such EQT Stockholder, relevant Affiliate or Arsenal Director Nominee, as applicable, has provided the Company with such
supporting documentation reasonably requested by the Company.

 

    12

     

    

 

ARTICLE
IV

MISCELLANEOUS

 

4.1           Remedies.
The parties to this Agreement acknowledge and agree that the covenants of the Company and the Stockholders set forth in this Agreement
may be enforced in equity by a decree requiring specific performance. In the event of a breach of any material provision of this
Agreement, the aggrieved party will be entitled to institute and prosecute a proceeding to enforce specific performance of such
provision, as well as to obtain damages for breach of this Agreement. Without limiting the foregoing, if any dispute arises concerning
the Transfer of any of the Shares subject to this Agreement or concerning any other provisions hereof or the obligations of the
parties hereunder, the parties to this Agreement agree that an injunction may be issued in connection therewith (including, without
limitation, restraining the Transfer of such Shares or rescinding any such Transfer). Such remedies shall be cumulative and non-exclusive
and shall be in addition to any other rights and remedies the parties may have under this Agreement or otherwise.

 

4.2           Entire Agreement; Amendment; Waiver. This Agreement, together with the Exhibits,
Annexes and Schedules hereto and the Registration Rights Agreement, sets forth the entire understanding of the parties, and as
of the date hereof supersedes all prior agreements and all other arrangements and communications, whether oral or written, with
respect to the subject matter hereof and thereof. The applicable Exhibits, Annexes and/or Schedules hereto may be amended to reflect
changes in the composition of the Stockholders as a result of Permitted Transfers, Transfers permitted under ARTICLE II,
exercise of Options, or additional Stockholders due to issuances of additional securities by the Company or its Subsidiaries. Amendments
to the applicable Exhibits, Annexes and/or Schedules hereto reflecting Permitted Transfers or Transfers permitted under ARTICLE
II or to reflect additional Stockholders due to issuances of additional securities by the Company pursuant to Section 4.12
or the exercise of Options shall become effective when a Joinder Agreement as executed by any new transferee or recipient of newly
issued securities of the Company or its Subsidiaries is filed with the Company as provided for in Section 4.12. This Agreement
may be amended, modified, supplemented, restated, waived or terminated only upon EQT Consent; provided, that any such amendment,
modification, supplement, restatement, waiver or termination which would have a material and disproportionate adverse effect on
the Non-EQT Institutional Stockholders and the Individual Stockholders as compared to the effect on the EQT Stockholders shall
also require the written consent of the Non-EQT Institutional Stockholders and the Individual Stockholders holding a majority of
the Shares held by the Non-EQT Institutional Stockholders and the Individual Stockholders; provided, further, that,
in the event the EQT Stockholders no longer hold any Shares, this Agreement may be amended, modified, supplemented, restated, waived
or terminated with the written consent of (a) the Company and (b) the Stockholders holding a majority of the Shares held by the
Stockholders. Without limiting the generality of the foregoing, without Arsenal Consent, no material and adverse amendment may
be made to the provisions of Section 2.2(a)(i)(A) which expressly grant rights to any Arsenal Stockholder. Notwithstanding
any provisions to the contrary contained herein, any party may waive any rights with respect to which such party is entitled to
benefits under this Agreement. No waiver of or consent to any departure from any provision of this Agreement shall be effective
unless signed in writing by the party entitled to the benefit thereof.

 

    13

     

    

 

4.3           Severability.
It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, the invalidity or
unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof, and this Agreement
shall be construed in all respects as if the invalid or unenforceable provision were omitted. Notwithstanding the foregoing, if
such provision could be more narrowly drawn so as not to be invalid or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so more narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity
or enforceability of such provision in any other jurisdiction.

 

4.4           Notices.
Unless otherwise specified herein, all notices, consents, approvals, reports, designations, requests, waivers, elections and other
communications authorized or required to be given pursuant to this Agreement shall be in writing and shall be deemed to have been
given (a) when personally delivered, (b) when transmitted via facsimile to the number set out below or on Exhibit A, as
applicable, if the sender receives confirmation of delivery or if the sender on the same or following business day sends a confirming
copy of such notice by a recognized delivery service (charges prepaid), (c) the day following the day (except if not a business
day then the next business day) on which the same has been delivered prepaid to a reputable national overnight air courier service,
(d) when transmitted via email (including via attached pdf document) to the email address set out below or on Exhibit A
if the sender on the same day sends a confirming copy of such notice by a recognized delivery service (charges prepaid) or (e)
the third business day following the day on which the same is sent by certified or registered mail, postage prepaid, in each case,
to the respective parties, as applicable, at the address, facsimile number or email address set forth below or on Exhibit A
hereto, as applicable (or such other address, facsimile number or email address as any Stockholder may specify by notice to
the Company in accordance with this Section 4.5):

 

(a)           For notices and communications to the Company, to:

 

Certara, Inc.

100 Overlook Center, Suite 101

Princeton, NJ 08540

Attention: Richard Traynor

Email: [                      ]

 

with a copy to (which shall not constitute actual
or constructive notice):

 

EQT Partners Inc.

1114 Avenue of the Americas

45th Floor

New York, NY 10036

Fax:    [                      ]

Attention:Eric C. Liu

Email: [                     ]

 

and a further copy to (which shall not constitute
actual or constructive notice):

 

Simpson Thacher & Bartlett LLP

2475 Hanover Street

Palo Alto, CA 94304

Fax:    [                      ]

Attention: William B. Brentani

Email: [                     ]

    14

     

    

 

(b)           for
notices and communications to the EQT Stockholders, to their respective addresses set forth in Exhibit A, with a copy to
(which shall not constitute actual or constructive notice):

 

Simpson Thacher & Bartlett LLP

2475 Hanover Street

Palo Alto, CA 94304

Fax:    [                      ]

Attention: William Brentani

Email: [                     ]

(c)           for notices and communications to the Arsenal Stockholders, the Other Institutional Stockholders, the Director Stockholders,
the Employee Stockholders or the Additional Stockholders, to their respective addresses set forth in Exhibit A.

 

By notice complying with the foregoing provisions of this Section
4.4, each party shall have the right to change the mailing address or facsimile number for future notices and communications
to such party.

 

4.5              
Binding Effect; Assignment. This Agreement shall be binding upon and inure to
the benefit of the parties hereto and to their respective transferees, successors and assigns; provided, however,
that no right or obligation under this Agreement may be assigned except as expressly provided herein (including in connection with
a Transfer of Shares in accordance herewith), it being understood that (i) the Company’s rights hereunder may be assigned
by the Company to any corporation which is the surviving entity in a merger, consolidation or like event involving the Company
and (ii) the rights of the Stockholders shall be automatically assigned with respect to any Share that is Transferred to a Permitted
Transferee thereof; provided, that such Permitted Transferee executes a counterpart to this Agreement and becomes bound
to the provisions hereof.

 

4.6              
Governing Law. All matters relating to the interpretation, construction, validity
and enforcement of this Agreement, including all claims (whether in contract or tort) that may be based upon, arise out of or relate
to this Agreement or the negotiation, execution or performance of this Agreement, shall be governed by and construed in accordance
with the domestic laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether
of the State of Delaware or any other jurisdiction) that would cause the application of laws of any jurisdiction other than the
State of Delaware.

 

4.7              
Termination. Without affecting any other provision of this Agreement requiring
termination of any rights in favor of any Stockholder or any transferee of Shares, the provisions of ARTICLE II (other than
Section 2.1, 2.2(a) and Section 2.3) shall terminate as to such Stockholder or transferee, when, pursuant
to and in accordance with this Agreement, such Stockholder or transferee, as the case may be, no longer owns any Shares; provided,
that termination pursuant to this Section 4.7 shall only occur in respect of a Stockholder after all Permitted Transferees
in respect thereof also no longer own any Shares. In addition, this Agreement shall automatically terminate at such time as no
Institutional Stockholder owns more than 5% of the Shares.

 

4.8              
Recapitalizations, Exchanges, Etc. The provisions of this Agreement shall apply,
to the full extent set forth herein with respect to Shares, to any and all shares of capital stock of the Company or any successor
or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in
exchange for, or in substitution of the Shares, by reason of a stock dividend, stock split, stock issuance, reverse stock split,
combination, recapitalization, reclassification, merger, consolidation or otherwise. 

 

    15

     

    

 

4.9              
 Action Necessary to Effectuate the Agreement. The parties hereto agree to take
or cause to be taken all such corporate and other action as may be reasonably necessary to effect the intent and purposes of this
Agreement.

 

4.10          
Purchase for Investment; Legend on Certificate. Each of the Stockholders acknowledges
that all of the Shares held by such Stockholder are being (or have been) acquired for investment and not with a view to the distribution
thereof and that no transfer, hypothecation or assignment of such Shares may be made except in compliance with applicable federal
and state securities laws. 

 

(a)               
Unless Section 4.10(b) applies, each certificate (or book entry share) evidencing Shares owned by a Stockholder and
which are subject to the terms of this Agreement shall bear the following legend, either as an endorsement or stamped or printed,
thereon, or in a notice to the Stockholder or transferee:

 

“The securities represented by this Certificate have
not been registered under the Securities Act of 1933, as amended, and may not be sold, offered for sale, pledged or hypothecated
in the absence of an effective registration statement as to the securities under said Act or an opinion of counsel reasonably satisfactory
to the Company and its counsel that such registration is not required.”

 

“The securities represented by this Certificate are
subject to the terms and conditions, including certain restrictions on transfer, of a Stockholders Agreement, dated as of [●],
2020, as amended and/or restated from time to time, and none of such securities, or any interest therein, shall be transferred,
pledged, encumbered or otherwise disposed of except as provided in that Stockholders Agreement. A copy of the Stockholders Agreement
is on file with the Secretary of the Company and will be mailed to any properly interested person without charge within five (5)
business days after receipt of a written request.”

 

(b)               
Each certificate (or book entry share) evidencing Shares owned by a Stockholder issued in a transaction registered under
the 1933 Act and which are subject to the terms of this Agreement shall bear the following legend, either as an endorsement or
stamped or printed, thereon, or in a notice to the Stockholder or transferee:

 

“The securities represented by this Certificate are
subject to the terms and conditions, including certain restrictions on transfer, of a Stockholders Agreement, dated as of [●],
2020, as amended and/or restated from time to time, and none of such securities, or any interest therein, shall be transferred,
pledged, encumbered or otherwise disposed of except as provided in that Stockholders Agreement. A copy of the Stockholders Agreement
is on file with the Secretary of the Company and will be mailed to any properly interested person without charge within five (5)
business days after receipt of a written request.”

 

All shares shall also bear all legends required
by federal and state securities laws. The legends set forth in this Section 4.10 shall be removed at the expense of the
Company at the request of a Stockholder at any time when they have ceased to be applicable (it being understood that the restriction
referred to in the second paragraph of Section 4.10(a) and in the legend in Section 4.10(b) shall cease and terminate
only when the provisions of ARTICLE II hereof cease to be applicable to any such Shares).

 

    16

     

    

  

4.11          
 Effectiveness of Transfers. All Shares Transferred by a Stockholder (other
than pursuant to an effective registration statement under the 1933 Act, pursuant to a Rule 144 transaction or pursuant to any
distribution of Shares by an EQT Stockholder to its partners, members or other investors after an initial Public Offering) shall,
except as otherwise expressly stated herein, be held by the transferee thereof subject to this Agreement. Such transferee shall,
except as otherwise expressly stated herein, have all the rights and be subject to all of the obligations of the transferor Stockholder
under this Agreement (as though such party had so agreed pursuant to Section 4.12) automatically and without requiring any
further act by such transferee or by any parties to this Agreement. Without affecting the preceding sentence, if such transferee
is not a Stockholder on the date of such Transfer, then such transferee, as a condition to such Transfer, shall confirm such transferee’s
obligations hereunder in accordance with Section 4.12. No Transfer of Shares by a Stockholder shall be registered on the
Company’s books and records, and such Transfer of Shares shall be null and void and not otherwise effective, unless any such
Transfer is made in accordance with the terms and conditions of this Agreement, and the Company is hereby authorized by all of
the Stockholders to enter appropriate stop transfer notations on its transfer records to give effect to this Agreement. 

 

4.12          
Additional Stockholders. Subject to the restrictions on Transfers of Shares
contained herein, any Person who is not already a Stockholder acquiring Shares from a Stockholder (other than pursuant to an effective
registration statement under the 1933 Act, pursuant to a Rule 144 transaction or pursuant to any distribution of Shares by an EQT
Stockholder to its partners, members or other investors after an initial Public Offering), shall, on or before the Transfer of
such Shares, sign a Joinder Agreement and deliver such agreement to the Company, and shall thereby become a party to this Agreement
to be bound hereunder as (i) an EQT Stockholder if a Permitted Transferee (other than the Company, or an Arsenal Stockholder, Other
Institutional Stockholder, Director Stockholder or Employee Stockholder) of an EQT Stockholder, (ii) an Arsenal Stockholder if
a Permitted Transferee (other than the Company, or an EQT Stockholder, Other Institutional Stockholder, Director Stockholder or
Employee Stockholder) of an Arsenal Stockholder, (iii) an Other Institutional Stockholder if a Permitted Transferee (other than
the Company, or an EQT Stockholder, Arsenal Stockholder, Director Stockholder or Employee Stockholder) of an Other Institutional
Stockholder, (iv) a Director Stockholder if a Permitted Transferee (other than the Company, or an EQT Stockholder, Arsenal Stockholder,
Other Institutional Stockholder or Employee Stockholder) of a Director Stockholder, (v) an Employee Stockholder if a Permitted
Transferee (other than the Company, or an EQT Stockholder, Arsenal Stockholder, Other Institutional Stockholder or Director Stockholder)
of an Employee Stockholder or (vi) an Additional Stockholder if such Person (other than the Company, or an EQT Stockholder, Arsenal
Stockholder, Other Institutional Stockholder, Director Stockholder or Employee Stockholder) does not fall within clause (i), (ii),
(iii), (iv) or (v) above. Each such additional Stockholder shall be listed on Exhibit A, as amended from time to time. 

 

    17

     

    

  

4.13          
Other Business Opportunities. 

 

(a)                Except
as otherwise provided in the Company’s certificate of incorporation or bylaws, the parties expressly acknowledge and
agree that to the fullest extent permitted by applicable law: (i) each of the Institutional Stockholders (in each case,
including (A) their respective Affiliates, (B) any portfolio company in which they or any of their respective affiliated
investment funds or Affiliates have made a debt or equity investment (and vice versa) and (C) their respective limited
partners, non-managing members or other similar direct or indirect investors) and each Stockholder Nominee has the right to,
and shall have no duty (fiduciary, contractual or otherwise) not to, directly or indirectly engage in and possess interests
in other business ventures of every type and description, including those engaged in the same or similar business activities
or lines of business as the Company or any of its Subsidiaries or deemed to be competing with the Company or any of its
Subsidiaries, on its own account, or in partnership with, or as an employee, officer, director or shareholder of any other
Person, with no obligation to offer to the Company or any of its Subsidiaries or any Non-Institutional Stockholder (or its
respective Affiliates) the right to participate therein; (ii) each of the Institutional Stockholders (in each case, including
(A) their respective Affiliates, (B) any portfolio company in which they or any of their respective affiliated investment
funds or Affiliates have made a debt or equity investment (and vice versa) and (C) their respective limited partners,
non-managing members or other similar direct or indirect investors) and each Stockholder Nominee may invest in, or provide
services to, any Person that directly or indirectly competes with the Company or any of its Subsidiaries; and (iii) in the
event that any of the Institutional Stockholders (in each case, including (A) their respective Affiliates, (B) any portfolio
company in which they or any of their respective affiliated investment funds or Affiliates have made a debt or equity
investment (and vice versa) and (C) their respective limited partners, non-managing members or other similar direct or
indirect investors) or any Stockholder Nominee acquires knowledge of a potential transaction or matter that may be a
corporate or other business opportunity for the Company or any of its Subsidiaries, such Person shall have no duty
(fiduciary, contractual or otherwise) to communicate or present such corporate opportunity to the Company or any of its
Subsidiaries or any Non-Institutional Stockholder (or its respective Affiliates), as the case may be, and, notwithstanding
any provision of this Agreement to the contrary, shall not be liable to the Company or any of its Subsidiaries or any
Non-Institutional Stockholder (or its respective Affiliates) for breach of any duty (fiduciary, contractual or otherwise) by
reason of the fact that such Person, directly or indirectly, pursues or acquires such opportunity for itself, directs such
opportunity to another Person or does not present such opportunity to the Company or any of its Subsidiaries or any
Non-Institutional Stockholder (or its respective Affiliates). For the avoidance of doubt, the parties acknowledge that this
paragraph is intended to disclaim and renounce, to the fullest extent permitted by applicable law, any right of the Company
or any of its Subsidiaries with respect to the matters set forth herein, and this paragraph shall be construed to effect such
disclaimer and renunciation to the fullest extent permitted by law.

 

(b)               
The Company, each of its Subsidiaries and each Non-Institutional Stockholder hereby, to the fullest extent permitted by
applicable law:

 

(i)                
confirms that no Institutional Stockholder nor any of its Affiliates has any duty to the Company
or any of its Subsidiaries or any Non-Institutional Stockholder other than the specific covenants and agreements set forth in this
Agreement;

 

(ii)             
acknowledges and agrees that (A) in the event of any conflict of interest between the Company
or any of its Subsidiaries, on the one hand, and any Institutional Stockholder or any of its Affiliates, on the other hand, such
Institutional Stockholder or any of its Affiliates (and any Stockholder Nominee) may act in its best interest and (B) none of the
Institutional Stockholders nor any of their respective Affiliates (or any Stockholder Nominee), shall be obligated (1) to reveal
to the Company or any of its Subsidiaries confidential information belonging to or relating to the business of such Person or any
of its Affiliates or (2) to recommend or take any action in its capacity as a Stockholder or director, as the case may be, that
prefers the interest of the Company or its Subsidiaries over the interest of such Person; and

 

(iii)           
waives any claim or cause of action against any of the Institutional Stockholders, any Stockholder
Nominee and any officer, employee, agent or Affiliate of any such Person that may from time to time arise in respect of a breach
by any such person of any duty or obligation disclaimed under Section 4.13(b)(i) or Section 4.13(b)(ii).

 

    18

     

    

  

(c)               
 Each of the parties hereto agrees that the waivers, limitations, acknowledgments and agreements set forth in this Section
4.13 shall not apply to any alleged claim or cause of action against any Institutional Stockholder based upon the breach or
nonperformance by such Institutional Stockholder of this Agreement or any other agreement to which such Person is a party.

 

(d)               
The provisions of this Section 4.13, to the extent that they restrict the duties and liabilities of any of the Institutional
Stockholders or any Stockholder Nominee otherwise existing at law or in equity, are agreed by the parties hereto to replace such
other duties and liabilities of the Institutional Stockholders or any such Stockholder Nominee to the fullest extent permitted
by applicable law.

 

4.14          
No Waiver. No course of dealing and no delay on the part of any party hereto
in exercising any right, power or remedy conferred by this Agreement shall operate as waiver thereof or otherwise prejudice such
party’s rights, powers and remedies. No single or partial exercise of any rights, powers or remedies conferred by this Agreement
shall preclude any other or further exercise thereof or the exercise of any other right, power or remedy.

 

4.15          
Costs and Expenses. Except as provided in Section 3.2, each party shall
pay its own costs and expenses incurred in connection with this Agreement, and any and all other documents furnished pursuant hereto
or in connection herewith.

 

4.16          
Counterpart. This Agreement may be executed in two or more counterparts each
of which shall be deemed an original but all of which together shall constitute one and the same instrument, and all signatures
need not appear on any one counterpart.

 

4.17          
Headings. All headings and captions in this Agreement are for purposes of reference
only and shall not be construed to limit or affect the substance of this Agreement.

 

4.18          
Third Party Beneficiaries. Except as provided in Section 4.13 and Section
3.1, nothing in this Agreement is intended or shall be construed to entitle any Person other than the Company and the Stockholders
to any claim, cause of action, right or remedy of any kind.

 

4.19          
Consent to Jurisdiction. The Company and each of the Stockholders, by its, his
or her execution hereof, (i) hereby irrevocably submit to the exclusive jurisdiction of the state and federal courts in the State
of Delaware for the purposes of any claim or action arising out of or based upon this Agreement or relating to the subject matter
hereof, (ii) hereby waive, to the extent not prohibited by applicable law, and agree not to assert by way of motion, as a defense
or otherwise, in any such claim or action, any claim that it or he is not subject personally to the jurisdiction of the above-named
courts, that its, his or her property is exempt or immune from attachment or execution, that any such proceeding brought in the
above-named court is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court and (iii)
hereby agree not to commence any claim or action arising out of or based upon this Agreement or relating to the subject matter
hereof other than before the above-named courts nor to make any motion or take any other action seeking or intending to cause the
transfer or removal of any such claim or action to any court other than the above-named courts whether on the grounds of inconvenient
forum or otherwise. The Company and each of the Stockholders hereby consent, to the fullest extent permitted by law, to service
of process in any such proceeding, and agree that service of process by registered or certified mail, return receipt requested,
at its address specified pursuant to Section 4.4 is reasonably calculated to give actual notice.

 

    19

     

    

  

4.20          
 WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH
CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE)
ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR
OTHERWISE), INQUIRY, PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN
ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER
ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 4.20 CONSTITUTES
A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT. ANY PARTY HERETO MAY FILE AN ORIGINAL
COUNTERPART OR A COPY OF THIS SECTION 4.20 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER
OF ITS RIGHT TO TRIAL BY JURY.

 

4.21          
Representations and Warranties. Each of the Stockholders executing this Agreement
hereby represents and warrants severally and not jointly to each of the other Stockholders and to the Company on the date hereof
(and in respect of Persons who become a party to this Agreement after the date hereof, such Stockholder hereby represents and warrants
to each of the other Stockholders and the Company on the date of its execution of a Joinder Agreement) as follows:

 

(a)               
Such Stockholder, to the extent applicable, is duly organized or incorporated, validly existing and in good standing under
the laws of the jurisdiction of its organization or incorporation and has all requisite power and authority to conduct its business
as it is now being conducted and is proposed to be conducted. Such Stockholder has the full power, authority and legal right to
execute, deliver and perform this Agreement. The execution, delivery and performance of this Agreement have been duly authorized
by all necessary action, corporate or otherwise, of such Stockholder. This Agreement has been duly executed and delivered by such
Stockholder and constitutes its, his or her legal, valid and binding obligation, enforceable against it, him or her in accordance
with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally.

 

(b)               
The execution and delivery by such Stockholder of this Agreement, the performance by such Stockholder of its, his or her
obligations hereunder by such Stockholder does not and will not violate (i) in the case of parties who are not individuals, any
provision of its organizational or constituent documents, (ii) any provision of any material agreement to which it, he or she is
a party or by which it, he or she is bound or (iii) any law, rule, regulation, judgment, order or decree to which it, he or she
is subject. No notice, consent, waiver, approval, authorization, exemption, registration, license or declaration is required to
be made or obtained by such Stockholder in connection with the execution, delivery or enforceability of this Agreement.

 

(c)               
Such Stockholder is not currently in violation of any law, rule, regulation, judgment, order or decree, which violation
could reasonably be expected at any time to have a material adverse effect upon such Stockholder’s ability to enter into
this Agreement or to perform its, his or her obligations hereunder. There is no pending legal action, suit or proceeding that would
materially and adversely affect the ability of such Stockholder to enter into this Agreement or to perform its, his or her obligations
hereunder.

 

    20

     

    

  

(d)               
 If such Stockholder is an individual and married, he or she has delivered to the Company a duly executed copy of a Spousal
Consent in the form attached hereto as Annex II (a “Spousal Consent”).

 

4.22          
Consents, Approvals and Actions.

 

(a)               
If any consent, approval or action of the EQT Stockholders is required at any time pursuant to this Agreement, such consent,
approval or action shall be deemed given if the holders of a majority of the Shares held by the EQT Stockholders at such time provide
such consent, approval or action in writing at such time.

 

(b)               
If any consent, approval or action of the Arsenal Stockholders is required at any time pursuant to this Agreement, such
consent, approval or action shall be deemed given if the holders of a majority of the Shares held by the Arsenal Stockholders at
such time provide such consent, approval or action in writing at such time.

 

(c)               
If any consent, approval or action of the Other Institutional Stockholders is required at any time pursuant to this Agreement,
such consent, approval or action shall be deemed given if the holders of a majority of the Shares held by the Other Institutional
Stockholders at such time provide such consent, approval or action in writing at such time.

 

(d)               
If any consent, approval or action of the Director Stockholders is required at any time pursuant to this Agreement, such
consent, approval or action shall be deemed given if the holders of a majority of the Shares held by the Director Stockholders
at such time provide such consent, approval or action in writing at such time.

 

(e)               
If any consent, approval or action of the Employee Stockholders is required at any time pursuant to this Agreement, such
consent, approval or action shall be deemed given if the holders of a majority of the Shares held by the Employee Stockholders
at such time provide such consent, approval or action in writing at such time.

 

(f)                
For purposes of clarity, the operation of this Section 4.22 shall not deprive any of the EQT Stockholders and/or
the Arsenal Stockholders, as applicable, of their respective rights to nominate directors pursuant to Section 2.2(a).

 

4.23          
No Third Party Liabilities. This Agreement may only be enforced against the
named parties hereto. All claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate
to any of this Agreement, or the negotiation, execution or performance of this Agreement (including any representation or warranty
made in or in connection with this Agreement or as an inducement to enter into this Agreement), may be made only against the entities
that are expressly identified as parties hereto, as applicable; and no past, present or future director, officer, employee, incorporator,
member, partner, stockholder, Affiliate, portfolio company in which any such party or any of its investment fund Affiliates have
made a debt or equity investment (and vice versa), agent, attorney or representative of any party hereto (including any Person
negotiating or executing this Agreement on behalf of a party hereto), unless a party to this Agreement, shall have any liability
or obligation with respect to this Agreement or with respect any claim or cause of action (whether in contract or tort) that may
arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement (including a representation
or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement).

 

    21

     

    

 

4.24          
 Aggregation of Securities. All securities held by the EQT Stockholders and
the Arsenal Stockholders, respectively, shall be aggregated together for purposes of determining the rights or obligations of any
member of the EQT Stockholders or the Arsenal Stockholders, respectively, or the application of any restrictions to any member
of the EQT Stockholders or the Arsenal Stockholders, respectively, under this Agreement in which such right, obligation or restriction
is determined by any ownership threshold. The EQT Stockholders and the Arsenal Stockholders, in each case, may allocate the ability
to exercise any rights of the EQT Stockholders or the Arsenal Stockholders, respectively, under this Agreement in any manner among
the EQT Stockholders or the Arsenal Stockholders, respectively, that the EQT Stockholders or the Arsenal Stockholders, respectively,
see fit. 

 

4.25          
Independent Nature of Stockholders’ Obligations and Rights. Each Stockholder
and the Company agrees that the arrangements contemplated by this Agreement are not intended to constitute the formation of a “group”
(as defined in section 13(d)(3) of the 1934 Act). Each Stockholder agrees that, for purposes of determining beneficial ownership
of such Stockholder, it shall disclaim any beneficial ownership by virtue of this Agreement of the Shares owned by the other Stockholders
(other than, in the case of the EQT Stockholders, as amongst the Stockholders within such defined group), and the Company agrees
to recognize such disclaimer in its 1934 Act and 1933 Act reports. The obligations of each Stockholder under this Agreement are
several and not joint with the obligations of any other Stockholder, and no Stockholder shall be responsible in any way for the
performance of the obligations of any other Stockholder under this Agreement. Nothing contained herein, and no action taken by
any Stockholder pursuant hereto, shall be deemed to constitute the Stockholders as, and the Company acknowledges that the Stockholders
do not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption
that the Stockholders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions
contemplated by this Agreement and the Company acknowledges that the Stockholders are not acting in concert or as a group, and
the Company shall not assert any such claim, in each case, with respect to such obligations or the transactions contemplated by
this Agreement. The decision of each Stockholder to enter into this Agreement has been made by such Stockholder independently of
any other Stockholder. Each Stockholder acknowledges that no other Stockholder has acted as agent for such Stockholder in connection
with such Stockholder making its investment in the Company and that no other Stockholder will be acting as agent of such Stockholder
in connection with monitoring such Stockholder’s investment in the Shares or enforcing its rights under this Agreement. The
Company and each Stockholder confirms that each Stockholder has had the opportunity to independently participate with the Company
and its subsidiaries in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors.
Each Stockholder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising
out of this Agreement, and it shall not be necessary for any other Stockholder to be joined as an additional party in any proceeding
for such purpose. The use of a single agreement to effectuate the rights and obligations contemplated hereby was solely in the
control of the Company, not the action or decision of any Stockholder, and was done solely for the convenience of the Company and
its subsidiaries and not because the Company was required to do so by any Stockholder. It is expressly understood and agreed that
each provision contained in this Agreement is between the Company and a Stockholder, solely, and not between the Company and the
Stockholders collectively and not between and among the Stockholders.

 

4.26          
Effectiveness. This Agreement shall become effective on the day immediately
preceding the date on which a registration statement on Form 8-A, or any successor form thereto, with respect to the Common Stock
first becomes effective under the 1934 Act. This Agreement shall automatically terminate if the Underwriting Agreement is terminated
prior to the completion of the initial public offering referenced therein for any reason or the initial Public Offering contemplated
by the Underwriting Agreement is not consummated on or before the tenth (10th) business day following the date of this
Agreement.

 

    22

     

    

  

[Remainder
of page intentionally left blank]

 

    23

     

    

  

IN WITNESS WHEREOF, each of the parties hereto
has duly executed this Agreement (or caused this Agreement to be executed on its behalf by its officer or representative thereunto
duly authorized) as of the date first above written.

	 	  
	 	THE COMPANY:
	 	 
	 	CERTARA, INC.
	 	(formerly known as EQT Avatar Topco, Inc.)
	 	  
	 	By:	              
	 	Name:
	 	Title:

 

[Signature Page to Stockholders Agreement]

 

     

     

    

  

	 	EQT STOCKHOLDERS:
	 	 
	 	EQT AVATAR PARENT L.P.
	 	 
	 	By:              EQT Avatar Parent GP LLC, its general partner
	 	  
	 	By:	            
	 	Name:
	 	Title:

 

[Signature Page to Stockholders Agreement]

 

     

     

    

  

	 	ARSENAL STOCKHOLDERS:
	 	 
	 	ARSENAL CAPITAL PARTNERS III LP
	 	 
	 	By:                Arsenal Capital Investment III LP, its general partner
	 	 
	 	By:                Arsenal Group LLC, its general partner
	 	  
	 	By:	               
	 	Name:
	 	Title:
	 	  
	 	ARSENAL CAPITAL PARTNERS III-B LP
	 	 
	 	By:                Arsenal Capital Investment III LP, its general partner
	 	 
	 	By:                Arsenal Group LLC, its general partner
	 	  
	 	By:	        
	 	Name:
	 	Title:

  

[Signature Page to Stockholders Agreement]

 

     

     

    

  

	 	OTHER INSTITUTIONAL STOCKHOLDERS
	 	 
	 	SANTO HOLDING (DEUTSCHLAND) GMBH
	 	 
	 	By:	                 
	 	Name:
	 	Title:
	 	  
	 	SAMPENSION PRIVATE EQUITY K/S
	 	 
	 	By:	   
	 	Name:
	 	Title:
	 	  
	 	KIRKBI INVEST A/S
	 	 
	 	By:	    
	 	Name:
	 	Title:
	 	  
	 	MONTE ROSA OPPORTUNITIES, SICAV-SIF, in relation to its segregated compartment Monte Rosa Co-Investments III
	 	 
	 	By:	     
	 	Name:
	 	Title:
	 	  
	 	PICTET PRIVATE EQUITY INVESTORS SA, as nominee on behalf of clients
	 	 
	 	By:	     
	 	Name:
	 	Title:
	 	  
	 	HOWARD HUGHES MEDICAL INSTITUTE
	 	 
	 	By:	             
	 	Name:
	 	Title:

 

[Signature Page to Stockholders Agreement]

 

     

     

    

  

	 	DIRECTOR STOCKHOLDERS:
	 	  
	 	By:	                    
	 	Name:
	 	  
	 	EMPLOYEE STOCKHOLDERS:
	 	  
	 	By:	 
	 	Name

  

[Signature Page to Stockholders Agreement]

 

     

     

    

 

Exhibit A

 

STOCKHOLDER
LIST

 

	STOCKHOLDERS	ADDRESS
	EQT STOCKHOLDERS
	[                           ]	[                           ]
	ARSENAL STOCKHOLDERS
	[                           ]	[                           ]
	[                           ]	[                           ]
	OTHER INSTITUTIONAL STOCKHOLDERS
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	DIRECTOR STOCKHOLDERS
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	[                           ]
	EMPLOYEE STOCKHOLDERS
	[                           ]	[                           ]

 

     

     

    

 

Annex I

 

FORM OF

JOINDER AGREEMENT

 

The undersigned is executing and delivering
this Joinder Agreement pursuant to that certain Stockholders Agreement of Certara, Inc., dated as of [●], 20[●] (as
amended, restated, supplemented or otherwise modified in accordance with the terms thereof, the “Stockholders Agreement”)
by and among Certara, Inc. (the “Company”), the EQT Stockholders, the Arsenal Stockholders and the other parties
thereto. Capitalized terms used but not defined in this Joinder Agreement shall have the respective meanings ascribed to such terms
in the Stockholders Agreement.

 

By executing and delivering this Joinder Agreement
to the Stockholders Agreement, the undersigned hereby adopts and approves the Stockholders Agreement and agrees, effective commencing
on the date hereof and as a condition to the undersigned’s becoming the transferee of Shares, to become a party to, and to
be bound by and comply with the provisions of, the Stockholders Agreement applicable to a Stockholder and [an EQT Stockholder][an
Arsenal Stockholder][an Other Institutional Stockholder][a Director Stockholder][an Employee Stockholder][an Additional Stockholder],
respectively, in the same manner as if the undersigned were an original signatory to the Stockholders Agreement.

 

The undersigned hereby represents and warrants
that, pursuant to this Joinder Agreement and the Stockholders Agreement, it is a Permitted Transferee of [an EQT Stockholder][an
Arsenal Stockholder][an Other Institutional Stockholder][a Director Stockholder][an Employee Stockholder][an Additional Stockholder]
and will be the lawful record owner of ___________ shares of Common Stock of the Company as of the date hereof. The undersigned
hereby covenants and agrees that it will take all such actions as required of a Permitted Transferee as set forth in the Stockholders
Agreement, including but not limited to conveying its record and beneficial ownership of any Shares and all rights, title and obligations
thereunder back to the initial transferor Stockholder or to another Permitted Transferee of the original transferor Stockholder,
as the case may be, immediately prior to such time that the undersigned no longer meets the qualifications of a Permitted Transferee
as set forth in the Stockholders Agreement.

 

The undersigned acknowledges and agrees that
Sections 4.1, 4.6, 4.19 and 4.20 of the Stockholders Agreement are incorporated herein by reference,
mutatis mutandis.

 

[Remainder of page intentionally left blank]

 

     

     

    

 

Accordingly, the undersigned has executed
and delivered this Joinder Agreement as of the    day of      , 20   .

 

	 	Signature

  

	 	Print Name

  

	 	Address:	 
	 	 	 
	 	 	 
	 	 	 

 

		Telephone:	      

 

		Facsimile:	      

 

		Email:	     

 

     

     

    

 

AGREED AND ACCEPTED

as of the ____ day of ____________,
_____.

 

CERTARA, INC.

  

	By: 	   	 
	Name:		 
	Title:		 

 

     

     

    

 

Annex II

 

FORM OF

SPOUSAL CONSENT

 

In consideration of the execution of that
certain Stockholders Agreement of Certara, Inc., dated as of [●], 20[●] (as amended, restated, supplemented or otherwise
modified in accordance with the terms thereof, the “Stockholders Agreement”) by and among Certara, Inc. (the
 “Company”), the EQT Stockholders, the Arsenal Stockholders and the other parties thereto, I,                                       , the spouse of                     , who is a party to the Stockholders Agreement, do hereby join with my spouse in executing the foregoing Stockholders Agreement
and do hereby agree to be bound by all of the terms and provisions thereof, in consideration of the issuance, acquisition or receipt
of Shares and all other interests I may have in the shares and securities subject thereto, whether the interest may be pursuant
to community property laws or similar laws relating to marital property in effect in the state or province of my or our residence
as of the date of signing this consent. Capitalized terms used but not defined herein shall have the meaning ascribed to such terms
in the Stockholders Agreement.

 

 

	Dated as of                   ,	 
	 	(Signature of Spouse)
	 	 
	 	 
	 	(Print Name of Spouse)Exhibit 10.2

 

 

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

BY AND AMONG

CERTARA, INC.

AND

THE PARTIES HERETO

 

Dated as of [●], 2020

 

 

     

     

    

 

TABLE OF
CONTENTS

 

Page

 

	Article I DEFINITIONS	1
	 	 
	SECTION 1.01.   Defined Terms	1
	SECTION 1.02.   Other Interpretive Provisions	7
	 	 
	Article II REGISTRATION RIGHTS	7
	 	 
	SECTION 2.01.   Demand Registration	7
	SECTION 2.02.   Shelf Registration	10
	SECTION 2.03.   Piggyback Registration	13
	SECTION 2.04.   Black-out Periods	14
	SECTION 2.05.   Registration Procedures	16
	SECTION 2.06.   Underwritten Offerings	20
	SECTION 2.07.   No Inconsistent Agreements; Additional Rights	22
	SECTION 2.08.   Registration Expenses	22
	SECTION 2.09.   Indemnification	23
	SECTION 2.10.   Rules 144
and 144A and Regulation 	26
	SECTION 2.11.   Limitation on Registrations and Underwritten Offerings	26
	SECTION 2.12.   Clear Market	26
	SECTION 2.13.   In-Kind Distributions	26
	 	 
	Article III MISCELLANEOUS	27
	 	 
	SECTION 3.01.   Term	27
	SECTION 3.02.   Injunctive Relief	27
	SECTION 3.03.   Attorneys’ Fees	27
	SECTION 3.04.   Notices	28
	SECTION 3.05.   Publicity and Confidentiality	28
	SECTION 3.06.   Amendment	28
	SECTION 3.07.   Successors, Assigns and Transferees	29
	SECTION 3.08.   Binding Effect	29
	SECTION 3.09.   Third Party Beneficiaries	29
	SECTION 3.10.   Governing Law; Jurisdiction	29
	SECTION 3.11.   Waiver of Jury Trial	30
	SECTION 3.12.   Severability	30
	SECTION 3.13.   Counterparts	30
	SECTION 3.14.   Headings	30
	SECTION 3.15.   Joinder	30
	SECTION 3.16.   Effectiveness	30
	SECTION 3.17.   Reinstatement of Original Registration Rights Agreement	31

 

    i 

     

    

 

REGISTRATION RIGHTS AGREEMENT

 

This Amended and Restated Registration Rights
Agreement (the “Agreement”) is made and entered into as of [●], 2020, by and among the Company
(as defined herein), the Institutional Investors (as defined herein) set forth on Schedule A hereto, the Holders (as
defined herein) set forth on Schedule B hereto and any other Person (as defined herein) who becomes a party hereto
from time to time in accordance with this Agreement.

 

WITNESSETH:

 

WHEREAS, the Company, the Institutional Investors
and certain other persons entered into a Registration Rights Agreement, dated as of August 15, 2017 (as may be amended, restated
or supplemented from time to time but not as of or after the date of this Agreement, the “Original Registration Rights
Agreement”);

 

WHEREAS, pursuant to
section 3.06 of the Original Registration Rights Agreement, the Company and the Institutional Investors are entering into this
Amended and Restated Registration Rights Agreement to amend and restate the Original Registration Rights Agreement so as to set
forth certain registration rights applicable to the Registrable Securities (as defined below) on the terms and conditions set forth
herein; and

 

WHEREAS, in accordance with the terms of the
A&R Limited Partnership Agreement (as defined below), all outstanding interests in the Partnership (as defined below), other
than those interests held by the Institutional Investors in their capacity as Partners (as defined in the Partnership Agreement),
were exchanged for Company Shares (as defined below).

 

NOW, THEREFORE, in consideration of the foregoing
and the mutual promises, covenants and agreements of the parties hereto, and for other good and valuable consideration the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

Article I

DEFINITIONS

 

Section 1.01.                
Defined Terms. As used in this Agreement, the following terms shall have the
following meanings:

 

“A&R Limited Partnership Agreement”
means the Amended and Restated Limited Partnership Agreement of the Partnership, dated as of August 15, 2017, as amended, restated,
supplemented or otherwise modified from time to time, by and among EQT Avatar Parent GP LLC, as general partner, and the additional
parties thereto from time to time.

 

“Acceptable Holders” means,
individually or collectively, EQT and their respective Permitted Assignees and Affiliates.

 

“Adverse Disclosure” means
public disclosure of material non-public information that, in the Board of Directors’ good faith judgment, after consultation
with independent outside counsel to the Company, would be required to be made in any Registration Statement filed with the SEC
by the Company so that such Registration Statement would not contain any untrue statement of material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein not materially misleading and would not be required
to be made at such time but for the filing, effectiveness or use of such Registration Statement, but which information the Company
has a bona fide, material business purpose for not disclosing publicly.

 

     

     

    

 

“Affiliate” has the meaning
specified in Rule 12b-2 under the Exchange Act; provided, that no Holder shall be deemed an Affiliate of the Company
or its Subsidiaries for purposes of this Agreement; provided, further, that neither portfolio companies (as such
term is commonly used in the private equity industry) of EQT or any of their Investment Fund Affiliates nor limited partners, non-managing
members or other similar direct or indirect third party investors in EQT or any of their Investment Fund Affiliates shall be deemed
to be Affiliates of any Institutional Investor. The term “Affiliated” has a correlative meaning.

 

“Agreement” has the meaning
set forth in the preamble.

 

“Arsenal Investors” has
the meaning set forth in the Stockholders Agreement.

 

“Board of Directors” means
the board of directors of the Company.

 

“Business Day” means any
day other than a Saturday, Sunday or a day on which commercial banks located in New York, New York are required or authorized by
law or executive order to be closed.

 

“Change of Control” means
(a) the sale or disposition, in one or a series of related transactions, of all or substantially all of the assets of the
Company and its Subsidiaries on a consolidated basis as determined under section 271 of the Delaware General Corporation Law,
to any “person” or “group” (as defined in section 13(d)(3) of the Exchange Act) (excluding the Acceptable
Holders) or (b) any person or group (excluding the Acceptable Holders) is or becomes the “beneficial owner”
(as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the total voting
power of the voting stock of the Company (a “Sale of Control”) and, following such Sale of Control, the
Acceptable Holders cease to have the right to designate a majority of the members of the Board of the Company; provided,
however, notwithstanding anything to the contrary in this definition or any provision of the Exchange Act, including section 13(d)-3
or 13(d)-5 of the Exchange Act and Rules 13d-3 and 13d-5 under the Exchange Act, (A) if any such person or group includes
one or more Acceptable Holders, the issued and outstanding Company Shares and Company Share Equivalents that are directly or indirectly
owned by the Acceptable Holders that are part of such person or group shall not be treated as being beneficially owned by such
person or group or any other member of such group for purposes of this definition, (B) such person or group shall not be deemed
to beneficially own Company Shares and Company Share Equivalents to be acquired by such person or group pursuant to a stock or
asset purchase agreement, merger agreement, option agreement, warrant agreement or similar agreement (or voting or option or similar
agreement related thereto) until the consummation of the acquisition of Company Shares and Company Share Equivalents in connection
with the transactions contemplated by such agreement and (C) such person or group will not be deemed to beneficially own Company
Shares and Company Share Equivalents of another Person as a result of its ownership of capital stock or other securities of such
other Person or such Person’s parent (or related contractual rights) unless it owns 50% or more of the total voting power
of the capital stock or other securities entitled to vote for the election of directors or similar governing body of such Person
or such Person’s parent.

 

“Company” means Certara,
Inc., a Delaware corporation, and any successors and assigns thereof.

 

“Company Public Sale” means
any offering of the Company’s equity securities for its own account or for the account of any other Person(s).

 

    2

     

    

 

“Company Share Equivalent”
means securities exercisable, exchangeable or convertible into Company Shares.

 

“Company Shares” means
the shares of voting common stock of the Company, any securities into which such shares of voting common stock shall have been
changed, or any securities resulting from any reclassification, recapitalization or similar transactions.

 

“Demand Company Notice”
has the meaning set forth in Section 2.01(c).

 

“Demand Notice” has the
meaning set forth in Section 2.01(a).

 

“Demand Registration” has
the meaning set forth in Section 2.01(a).

 

“Demand Registration Statement”
has the meaning set forth in Section 2.01(a).

 

“Demand Suspension” has
the meaning set forth in Section 2.01(d).

 

“Eligibility Notice” has
the meaning set forth in Section 2.02(a)(i).

 

“EQT” means EQT Avatar
Parent L.P., a Delaware limited partnership, and any successors and assigns thereof.

 

“Exchange Act” means the
Securities Exchange Act of 1934, as amended, and any successor thereto, and any rules and regulations promulgated thereunder, all
as the same shall be in effect from time to time.

 

“Excluded Holder” means
any Holder that is a former officer, director, employee or consultant of the Company or any of its Subsidiaries as of the applicable
date of determination.

 

“FINRA” means the U.S.
Financial Industry Regulatory Authority.

 

“Form S-1” means a
registration statement on Form S-1 under the Securities Act, or any comparable or successor form or forms thereto.

 

“Form S-3” means a
registration statement on Form S-3 under the Securities Act, or any comparable or successor form or forms thereto.

 

“Form S-4” means a
registration statement on Form S-4 under the Securities Act, or any comparable or successor form or forms thereto.

 

“Form S-8” means a
registration statement on Form S-8 under the Securities Act, or any comparable or successor form or forms thereto.

 

“Holder” means any holder
of Registrable Securities that is a party hereto or that succeeds to rights hereunder pursuant to Section 3.07.

 

“Impacted Holder” has the
meaning set forth in Section 3.06.

 

“Institutional Investors”
means EQT and their respective Affiliates that are direct or indirect equity investors in the Company and any Permitted Assignee
thereof that becomes a party hereto as an Institutional Investor, together with each of their respective successors.

 

    3

     

    

 

“Investment
Fund” means, collectively, (x) a private equity or other investment fund that (A) makes investments in multiple
portfolio companies and was not formed primarily to invest in the Company or its Subsidiaries or (B) is an alternative investment
vehicle for a fund described in clause (A) and (y) any Person directly or indirectly wholly-owned by any private equity or other
investment fund (or group of Affiliated private equity or other investment funds) described in clause (x) and/or any general partner
or managing member who is an Affiliate thereof.

 

“IPO” means (i) the
first registered initial public offering in the United States or foreign jurisdiction of the equity securities of the Company or
any entity into which the equity securities of the Company may be converted in connection with such offering, pursuant to an effective
registration statement under the Securities Act (other than a registration statement on Forms S-4 or S-8 or any similar form) or
pursuant to other applicable foreign laws or (ii) the date of effectiveness of a registration of a class of securities of
the Company or any entity into which the securities of the Company may be converted in connection with such registration under
the Exchange Act to be traded on a national securities exchange that has registered with the SEC under section 6 of the Exchange
Act; provided, that, for the avoidance of doubt, the closing contemplated by a registration statement on Form S-1 publicly
filed by the Company with the SEC shall constitute an IPO.

 

“Issuer Free Writing Prospectus”
means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer of Registrable
Securities.

 

“Long-Form Registration”
has the meaning set forth in Section 2.01(a).

 

“Loss” or “Losses”
has the meaning set forth in Section 2.09(a).

 

“Majority Impacted Holders”
means the Impacted Holders holding a majority of the Registrable Securities held by all Impacted Holders as of the applicable date
of determination.

 

“Marketed Underwritten Offering”
means any Underwritten Offering (including a Marketed Underwritten Shelf Take-Down, but, for the avoidance of doubt, not including
any Shelf Take-Down that is not a Marketed Underwritten Shelf Take-Down) that involves a customary “road show” (including
an “electronic road show”) or other substantial marketing effort by the Company and the underwriters over a period
of at least 48 hours.

 

“Marketed
Underwritten Shelf Take-Down” has the meaning set forth in Section 2.02(e)(iii).

 

“Marketed
Underwritten Shelf Take-Down Notice” has the meaning set forth in Section 2.02(e)(iii).

 

“Participating
Holder” means, with respect to any Registration, any Holder of Registrable Securities covered by the applicable Registration
Statement.

 

“Partnership”
means EQT Avatar Parent L.P., a Delaware limited partnership, and any successors and assigns thereof. 

 

“Permitted
Assignee” has the meaning set forth
in Section 3.07(a).

 

“Person”
means any individual, partnership, corporation, limited liability company, unincorporated organization, trust or joint venture,
or a governmental agency or political subdivision thereof or any other entity.

 

    4

     

    

 

“Piggyback Registration”
has the meaning set forth in Section 2.03(a).

 

“Prospectus” means the
prospectus included in any Registration Statement, all amendments and supplements to such prospectus, including pre- and post-effective
amendments to such Registration Statement, and all other material incorporated by reference in such prospectus.

 

“Registrable Securities”
means any Company Shares and any securities that may be issued or distributed or be issuable or distributable in respect of, or
in substitution for, any Company Shares by way of conversion, exercise, dividend, stock split or other distribution, merger, consolidation,
exchange, recapitalization or reclassification or similar transaction, in each case whether now owned or hereinafter acquired;
provided, however, that any such Registrable Securities shall cease to be Registrable Securities to the extent (i) a
Registration Statement with respect to the sale of such Registrable Securities has been declared effective under the Securities
Act and such Registrable Securities have been disposed of in accordance with the plan of distribution set forth in such Registration
Statement, (ii) such Registrable Securities have been distributed pursuant to Rule 144 or Rule 145 of the Securities
Act (or any successor rule or other exemption from the registration requirements of the Securities Act), (iii) a Registration
Statement on Form S-8 (or any successor form) covering the resale of such securities is effective, (iv) such security
ceases to be outstanding or (v) when a Holder (other than the Institutional Investors or any of their respective Affiliates)
is able to dispose of such Registrable Securities held by it pursuant to Rule 144 under the Securities Act without any limitation.
For the avoidance of doubt, it is understood that, (i) with respect to any Registrable Securities that are subject to vesting conditions,
all vesting conditions must be satisfied and such Registrable Securities vested prior to the exercise of any registration rights
with respect to such Registrable Securities pursuant to this Agreement and/or sale of such Registrable Securities, (ii) with respect
to any Registrable Securities for which a Holder holds vested but unexercised options or other Company Share Equivalents at such
time exercisable for, convertible into or exchangeable for Company Shares, to the extent that such Registrable Securities are to
be sold under a registration statement pursuant to this Agreement, such Holder must exercise the relevant option or exercise, convert
or exchange such other relevant Company Share Equivalent and agree to transfer the underlying Registrable Securities (in each case,
net of any amounts required to be withheld by the Company in connection with such exercise).

 

“Registration” means a
registration with the SEC of the Company’s securities for offer and sale to the public under a Registration Statement. The
terms “Register” and “Registered” shall have correlative meanings.

 

“Registration Expenses”
has the meaning set forth in Section 2.08.

 

“Registration Statement”
means any registration statement of the Company that covers Registrable Securities pursuant to the provisions of this Agreement
filed with, or to be filed with, the SEC under the rules and regulations promulgated under the Securities Act, including any related
Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and all exhibits
and all material incorporated by reference in such registration statement.

 

“Representatives” means,
with respect to any Person, any of such Person’s officers, directors, employees, agents, attorneys, accountants, actuaries,
consultants, equity financing partners or financial advisors or other Person associated with, or acting on behalf of, such Person.

 

“Rule 144” means Rule 144
(or any successor provisions) under the Securities Act.

 

“S-3 Eligibility Date”
has the meaning set forth in Section 2.02(a)(i).

 

    5

     

    

 

“S-3 Shelf Notice” has
the meaning set forth in Section 2.02(a)(i).

 

“SEC” means the Securities
and Exchange Commission.

 

“Securities Act” means
the Securities Act of 1933, as amended, and any successor thereto, and any rules and regulations promulgated thereunder, all as
the same shall be in effect from time to time.

 

“Shelf Holder” has the
meaning set forth in Section 2.02(c).

 

“Shelf Notice” has the
meaning set forth in Section 2.02(a)(ii).

 

“Shelf Period” has the
meaning set forth in Section 2.02(b).

 

“Shelf Registration” means
a Registration effected pursuant to Section 2.02.

 

“Shelf Registration Statement”
means a Registration Statement of the Company filed with the SEC on either (i) Form S-3 (or any successor or similar
short-form registration statement) or (ii) if the Company is not permitted to file a Registration Statement on Form S-3,
a Registration Statement on Form S-1 (or any successor or similar registration statement), in each case for an offering to
be made on a delayed or continuous basis pursuant to Rule 415 under the Securities Act (or any successor provision) covering
all or any portion of the Registrable Securities, as applicable.

 

“Shelf Suspension” has
the meaning set forth in Section 2.02(d).

 

“Shelf Take-Down” has the
meaning set forth in Section 2.02(e)(i).

 

“Short-Form Registration”
has the meaning set forth in Section 2.01(a).

 

“Special Registration”
has the meaning set forth in Section 2.12.

 

“Stockholders Agreement”
means the Stockholders Agreement of the Company, dated as of [●], 2020, by and among the EQT Stockholders (as defined
therein), the Arsenal Stockholders (as defined therein) and the additional parties thereto from time to time, as amended, restated,
supplemented or otherwise modified from time to time.

 

“Subsidiary”
means, with respect to any Person, any entity of which (i) a majority of the total voting power of shares of stock or equivalent
ownership interests entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers,
trustees or other members of the applicable governing body thereof is at the time owned or controlled, directly or indirectly,
by that Person or one or more of the Subsidiaries of that Person or a combination thereof, or (ii) if no such governing body
exists at such entity, a majority of the total voting power of shares of stock or equivalent ownership interests of the entity
is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination
thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a limited liability
company, company, association or other business entity if such Person or Persons shall be allocated a majority of limited liability
company, company, association or other business entity gains or losses or is (or controls) the managing member or general partner
of such limited liability company, company, association or other business entity.

 

“Underwritten Offering”
means a Registration in which securities of the Company are sold to an underwriter or underwriters on a firm commitment basis for
reoffering to the public.

 

“Underwritten Shelf Take-Down Notice”
has the meaning set forth in Section 2.02(e)(ii).

 

    6

     

    

 

Section 1.02.                
Other Interpretive Provisions. (a) In this Agreement, except as otherwise provided:

 

(i)                
A reference to an Article, Section, Schedule or Exhibit is a reference to an Article or Section of, or Schedule or
Exhibit to, this Agreement, and references to this Agreement include any recital in or Schedule or Exhibit to this
Agreement.

 

(ii)              
The Schedules and Exhibits form an integral part of and are hereby incorporated by reference into this Agreement.

 

(iii)            
Headings and the Table of Contents are inserted for convenience only and shall not affect the construction or interpretation
of this Agreement.

 

(iv)             
Unless the context otherwise requires, words importing the singular include the plural and vice versa, words importing the
masculine include the feminine and vice versa, and words importing persons include corporations, associations, partnerships, joint
ventures and limited liability companies and vice versa.

 

(v)               
Unless the context otherwise requires, the words “hereof” and “herein”, and words of similar meaning
refer to this Agreement as a whole and not to any particular Article, Section or clause. The words “include”, “includes”
and “including” shall be deemed to be followed by the words “without limitation.”

 

(vi)             
A reference to any legislation or to any provision of any legislation shall include any amendment, modification or re-enactment
thereof and any legislative provision substituted therefor.

 

(vii)           
All determinations to be made by the Institutional Investors hereunder shall be made by the Institutional Investors in their
sole discretion, and the Institutional Investors may determine, in their sole discretion, whether or not to take actions that are
permitted, but not required, by this Agreement to be taken by the Institutional Investors, including the giving of consents required
hereunder.

 

(b)               
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity
or question of intention or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto,
and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions
of this Agreement.

 

Article II

REGISTRATION RIGHTS

 

Section 2.01.                
Demand Registration.

 

(a)                Demand
by Institutional Investors. At any time, the Institutional Investors may, subject to Section 2.11, make a
written request (a “Demand Notice”) to the Company for Registration of all or part of the Registrable
Securities held by the Institutional Investors (i) on Form S-1
(a “Long-Form Registration”) or (ii) on Form S-3
(a “Short-Form Registration”) if the Company qualifies to use such short form (any such
requested Long-Form Registration or Short-Form Registration, a “Demand Registration”). Each
Demand Notice shall specify the aggregate amount of Registrable Securities of the Institutional Investors to be registered
and the intended methods of disposition thereof. Subject to Section 2.11, after delivery of such Demand Notice,
the Company (x) shall file promptly (and, in any event, within (i) ninety (90) days in the case of a request
for a Long-Form Registration or (ii) thirty (30) days in the case of a request for a
Short-Form Registration, in each case, following delivery of such Demand Notice) with the SEC a Registration Statement
(which the Company shall designate as an automatically effective Registration Statement if the Company qualifies at such time
to file such a Registration Statement) relating to such Demand Registration (a “Demand Registration
Statement”), and (y) shall use its reasonable best efforts to cause such Demand Registration Statement to
promptly be declared effective under (x) the Securities Act (if such Registration Statement is not automatically
effective) and (y) the “Blue Sky” laws of such jurisdictions as any Participating Holder or any
underwriter, if any, reasonably requests.

 

    7

     

    

 

(b)               
Demand Withdrawal. The Institutional Investors may withdraw their Registrable Securities from a Demand Registration
at any time prior to the effectiveness of the applicable Demand Registration Statement. Upon delivery of a notice by the Institutional
Investors to such effect, the Company shall cease all efforts to secure effectiveness of the applicable Demand Registration Statement.
For the avoidance of doubt, the Institutional Investors shall not have any liability or obligation to any other Holder following
their determination to terminate, withdraw and/or delay any Demand Registration initiated by them under this Section 2.01.

 

(c)               
Demand Company Notice. Subject to Section 2.11, promptly upon delivery of any Demand Notice (but in no
event more than five (5) Business Days following delivery of such Demand Notice), the Company shall deliver a written notice
(a “Demand Company Notice”) of any such Registration request to all Holders (other than the Institutional
Investors), and the Company shall include in such Demand Registration all such Registrable Securities of such Holders which the
Company has received written requests for inclusion therein within ten (10) Business Days after the date that such Demand
Company Notice has been delivered. All requests made pursuant to this Section 2.01(c) shall specify the aggregate amount
of Registrable Securities of such Holder to be registered.

 

(d)               
Delay in Filing; Suspension of Registration. If the Company shall furnish to the Participating Holders a certificate
signed by the Chief Executive Officer or equivalent senior executive officer of the Company stating that the filing, effectiveness
or continued use of a Demand Registration Statement would require the Company to make an Adverse Disclosure, then the Company may
delay the filing (but not the preparation of) or initial effectiveness of, or suspend use of, the Demand Registration Statement
(a “Demand Suspension”); provided, however, that the Company, unless otherwise approved in
writing by the Institutional Investors, shall not be permitted to exercise aggregate Demand Suspensions and Shelf Suspensions more
than twice, or for more than an aggregate of sixty (60) days, in each case, during any twelve (12) month period; provided,
further, that in the event of a Demand Suspension, such Demand Suspension shall terminate at such earlier time as the Company
would no longer be required to make any Adverse Disclosure. Each Participating Holder shall keep confidential the fact that a Demand
Suspension is in effect, the certificate referred to above and its contents unless and until otherwise notified by the Company,
except (A) for disclosure to such Participating Holder’s employees, agents and professional advisers who reasonably
need to know such information for purposes of assisting the Participating Holder with respect to its investment in the Company
Shares and agree to keep it confidential, (B) for disclosures to the extent required in order to comply with reporting obligations
to its limited partners or other direct or indirect investors who have agreed to keep such information confidential, (C) if
and to the extent such matters are publicly disclosed by the Company or any of its Subsidiaries or any other Person that, to the
actual knowledge of such Participating Holder, was not subject to an obligation or duty of confidentiality to the Company and its
Subsidiaries, (D) as required by law, rule or regulation, (E) for disclosures to potential limited partners or investors
of a Participating Holder who have agreed to keep such information confidential and (F) for disclosures to potential transferees
of a Holder’s Registrable Securities who have agreed to keep such information confidential. In the case of a Demand Suspension,
the Participating Holders agree to suspend use of the applicable Prospectus and any Issuer Free Writing Prospectus in connection
with any sale or purchase of, or offer to sell or purchase, Registrable Securities, upon delivery of the notice referred to above.
The Company shall immediately notify the Participating Holders upon the termination of any Demand Suspension, and (i) in the
case of a Demand Registration Statement that has not been declared effective, shall promptly thereafter file the Demand Registration
Statement and use its reasonable best efforts to have such Demand Registration Statement declared effective under the Securities
Act and (ii) in the case of an effective Demand Registration Statement, shall amend or supplement the Prospectus and any Issuer
Free Writing Prospectus, if necessary, so it does not contain any untrue statement or omission and furnish to the Participating
Holders such numbers of copies of the Prospectus and any Issuer Free Writing Prospectus as so amended or supplemented as the Participating
Holders may reasonably request. The Company agrees, if necessary, to supplement or make amendments to the Demand Registration Statement
if required by the registration form used by the Company for the applicable Registration or by the instructions applicable to such
registration form or by the Securities Act, or as may reasonably be requested by the Institutional Investors.

 

    8

     

    

 

(e)               
Underwritten Offering. If the Institutional Investors so request, an offering of Registrable Securities pursuant
to a Demand Registration shall be in the form of an Underwritten Offering, and the Institutional Investors shall have the right
to select the managing underwriter or underwriters to administer the offering. If the Institutional Investors intend to sell the
Registrable Securities covered by their demand by means of an Underwritten Offering, the Institutional Investors shall so advise
the Company as part of its Demand Notice, and the Company shall include such information in the Demand Company Notice.

 

(f)                
Priority of Securities Registered Pursuant to Demand Registrations. If the managing underwriter or underwriters of
a proposed Underwritten Offering of the Registrable Securities included in a Demand Registration advise the Board of Directors
in writing (with a copy provided to the Institutional Investors requesting participation in such Demand Registration) that, in
its or their opinion, the number of securities requested to be included in such Demand Registration exceeds the number which can
be sold in such offering without being likely to have a significant adverse effect on the price, timing or distribution of the
securities offered or the market for the securities offered, the securities to be included in such Demand Registration (i) first,
shall be allocated pro rata among the Holders that have requested to participate in such Demand Registration based on the
relative number of Registrable Securities then held by each such Holder (provided, that any securities thereby allocated
to a Holder that exceed such Holder’s request shall be reallocated among the remaining requesting Holders in like manner),
(ii) second, and only if all the securities referred to in clause (i) have been included in such Registration, the
number of securities that the Company proposes to include in such Registration that, in the opinion of the managing underwriter
or underwriters, can be sold without having such adverse effect and (iii) third, and only if all of the securities
referred to in clause (ii) have been included in such Registration, any other securities eligible for inclusion in such Registration
that, in the opinion of the managing underwriter or underwriters, can be sold without having such adverse effect.

 

    9

     

    

 

Section 2.02.                
Shelf Registration.

 

(a)               
Filing.

 

(i)                
Following the IPO, the Company shall use its reasonable best efforts to qualify for Registration on Form S-3 for secondary
sales. Promptly following the date on which the Company becomes eligible to Register on Form S-3 (the “S-3 Eligibility
Date”), the Company shall notify, in writing, the Institutional Investors of such eligibility and its intention to file
and maintain a Shelf Registration Statement on Form S-3 covering the Registrable Securities held by the Institutional Investors
(the “Eligibility Notice”). Promptly following receipt of such Eligibility Notice (but in no event more
than ten (10) days after receipt of such Eligibility Notice), the Institutional Investors shall deliver a written notice to
the Company, which notice shall specify the aggregate amount of Registrable Securities held by the Institutional Investors to be
covered by such Shelf Registration Statement and the intended methods of distribution thereof (the “S-3 Shelf Notice”).
Following delivery of the S-3 Shelf Notice, the Company (x) shall file promptly (and, in any event, within the earlier of
(i) thirty (30) days of receipt of the S-3 Shelf Notice and (ii) forty (40) days after delivery of the Eligibility
Notice) with the SEC such Shelf Registration Statement (which shall be an automatic Shelf Registration Statement if the Company
qualifies at such time to file such a Shelf Registration Statement) relating to the offer and sale of all Registrable Securities
requested for inclusion therein by the Institutional Investors and, to the extent requested under Section 2.02(c),
the other Holders from time to time in accordance with the methods of distribution elected by such Holders (to the extent permitted
in this Section 2.02) and set forth in the Shelf Registration Statement and (y) shall use its reasonable best
efforts to cause such Shelf Registration Statement to be promptly declared effective under the Securities Act (including upon the
filing thereof if the Company qualifies to file an automatic Shelf Registration Statement); provided, however, that
if the Institutional Investors reasonably believe that the Company will become S-3 eligible and delivers a S-3 Shelf Notice following
the IPO but prior to the S-3 Eligibility Date, the Company shall not be obligated to file (but shall be obligated to prepare) such
Shelf Registration Statement on Form S-3.

 

(ii)              
Subject to the right to deliver a Shelf Notice in the manner contemplated by the first proviso below, at any time following
the first anniversary of the IPO, to the extent that the Company is not eligible to file or maintain a Shelf Registration Statement
on Form S-3 as contemplated by Section 2.02(a)(i), the Institutional Investors may, subject to Section 2.11,
make a written request to the Company to file a Shelf Registration Statement on Form S-1 (a “Shelf Notice”),
which Shelf Notice shall specify the aggregate amount of Registrable Securities of the Institutional Investors to be registered
therein and the intended methods of distribution thereof. Following the delivery of a Shelf Notice, the Company (x) shall
file promptly (and, in any event, within ninety (90) days following delivery of such Shelf Notice) with the SEC such Shelf
Registration Statement relating to the offer and sale of all Registrable Securities requested for inclusion therein by the Institutional
Investors and, to the extent requested under Section 2.02(c), the other Holders from time to time in accordance with
the methods of distribution elected by such Holders (to the extent permitted in this Section 2.02) and set forth in
the Shelf Registration Statement (provided, however, that if a Shelf Notice is delivered prior to the first anniversary
of the IPO, the Company shall not be obligated to file (but shall be obligated to prepare) such Shelf Registration Statement prior
to the first anniversary of the IPO) and (y) shall use its reasonable best efforts to cause such Shelf Registration Statement
to be promptly declared effective under the Securities Act. If, on the date of any such request (or, in the event of a request
that is delivered prior to the first anniversary of the IPO, on the date following the first anniversary of the IPO), the Company
does not qualify to file a Shelf Registration Statement under the Securities Act, the provisions of this Section 2.02
shall not apply, and the provisions of Section 2.01 shall apply instead.

 

    10

     

    

 

(b)               
Continued Effectiveness. The Company shall use its reasonable best efforts to keep any Shelf Registration Statement
filed pursuant to Section 2.02(a) continuously effective under the Securities Act in order to permit the Prospectus
forming a part thereof to be usable by Shelf Holders until the earliest of (i) the date as of which all Registrable Securities
have been sold pursuant to the Shelf Registration Statement or another Registration Statement filed under the Securities Act (but
in no event prior to the applicable period referred to in section 4(a)(3) of the Securities Act and Rule 174 thereunder),
(ii) the date as of which each of the Shelf Holders is permitted to sell its Registrable Securities without Registration pursuant
to Rule 144 without volume limitation or other restrictions on transfer thereunder and (iii) such shorter period as the
Institutional Investors with respect to such Shelf Registration shall agree in writing (such period of effectiveness, the “Shelf
Period”). Subject to Section 2.02(d), the Company shall not be deemed to have used its reasonable best efforts
to keep the Shelf Registration Statement effective during the Shelf Period if the Company voluntarily takes any action or omits
to take any action that would result in Shelf Holders not being able to offer and sell any Registrable Securities pursuant to such
Shelf Registration Statement during the Shelf Period, unless such action or omission is (x) a Shelf Suspension permitted pursuant
to Section 2.02(d) or (y) required by applicable law, rule or regulation.

 

(c)               
Company Notices. Promptly after delivery of a S-3 Shelf Notice or Shelf Notice pursuant to Section 2.02(a)
(but in no event more than ten (10) Business Days after delivery of such S-3 Shelf Notice or the Shelf Notice, as applicable),
the Company shall deliver a written notice of the S-3 Shelf Notice or the Shelf Notice, as applicable, to all Holders other than
the Institutional Investors and the Company shall include in such Shelf Registration all Registrable Securities of such Holders
which the Company has received written requests for inclusion therein within ten (10) Business Days after such written notice
is delivered to such Holders (each such Holder delivering such a request, together with the Institutional Investors, if applicable,
a “Shelf Holder”). If the Company is permitted by applicable law, rule or regulation to add selling stockholders
to a Shelf Registration Statement without filing a post-effective amendment, a Holder may request the inclusion of any amount of
such Holder’s Registrable Securities in such Shelf Registration Statement at any time or from time to time after the filing
of a Shelf Registration Statement, and the Company shall add such Registrable Securities to the Shelf Registration Statement as
promptly as reasonably practicable, and such Holder shall be deemed a Shelf Holder.

 

(d)               
Delay in Filing; Suspension of Registration. If the Company shall furnish to the Shelf Holders a certificate signed
by the Chief Executive Officer or equivalent senior executive officer of the Company stating that the filing, effectiveness or
continued use of a Shelf Registration Statement filed pursuant to Section 2.02(a) would require the Company to make
an Adverse Disclosure, then the Company may delay the filing (but not the preparation of) or initial effectiveness of, or suspend
use of the Shelf Registration Statement (a “Shelf Suspension”); provided, however, that the
Company, unless otherwise approved in writing by the Institutional Investors, shall not be permitted to exercise aggregate Demand
Suspensions and Shelf Suspensions more than twice, or for more than an aggregate of sixty (60) days, in each case, during
any 12-month period; provided, further, that in the event of a Shelf Suspension, such Shelf Suspension shall terminate
at such earlier time as the Company would no longer be required to make any Adverse Disclosure. Each Shelf Holder shall keep confidential
the fact that a Shelf Suspension is in effect, the certificate referred to above and its contents unless and until otherwise notified
by the Company, except (A) for disclosure to such Shelf Holder’s employees, agents and professional advisers who reasonably
need to know such information for purposes of assisting the Holder with respect to its investment in the Company Shares and agree
to keep it confidential, (B) for disclosures to the extent required in order to comply with reporting obligations to its limited
partners or other direct or indirect investors who have agreed to keep such information confidential, (C) if and to the extent
such matters are publicly disclosed by the Company or any of its Subsidiaries or any other Person that, to the actual knowledge
of such Shelf Holder, was not subject to an obligation or duty of confidentiality to the Company and its Subsidiaries, (D) as
required by law, rule or regulation, (E) for disclosures to potential limited partners or investors of a Participating Holder
who have agreed to keep such information confidential and (F) for disclosures to potential transferees of a Holder’s
Registrable Securities who have agreed to keep such information confidential. In the case of a Shelf Suspension, the Holders agree
to suspend use of the applicable Prospectus and any Issuer Free Writing Prospectus in connection with any sale or purchase of,
or offer to sell or purchase, Registrable Securities, upon delivery of the notice referred to above. The Company shall immediately
notify the Shelf Holders upon the termination of any Shelf Suspension, and (i) in the case of a Shelf Registration Statement
that has not been declared effective, shall promptly thereafter file the Shelf Registration Statement and use its reasonable best
efforts to have such Shelf Registration Statement declared effective under the Securities Act and (ii) in the case of an effective
Shelf Registration Statement, shall (x) amend or supplement the Prospectus and any Issuer Free Writing Prospectus, if necessary,
so it does not contain any untrue statement or omission and furnish to the Shelf Holders such numbers of copies of the Prospectus
and any Issuer Free Writing Prospectus as so amended or supplemented as the Shelf Holders may reasonably request and (y) if
applicable, cause any post-effective amendment to the Shelf Registration Statement to become effective. The Company agrees, if
necessary, to supplement or make amendments to the Shelf Registration Statement if required by the registration form used by the
Company for the applicable Registration or by the instructions applicable to such registration form or by the Securities Act or
the rules or regulations promulgated thereunder, or as may reasonably be requested by the Institutional Investors.

 

    11

     

    

 

(e)               
Shelf Take-Downs.

 

(i)                
An offering or sale of Registrable Securities pursuant to a Shelf Registration Statement (each, a “Shelf Take-Down”)
may be initiated only by the Institutional Investors. Except as set forth in Section 2.02(e)(iii) with respect to Marketed
Underwritten Shelf Take-Downs, the Company shall not be required to permit the offer and sale of Registrable Securities by other
Shelf Holders in connection with any such Shelf Take-Down initiated by the Institutional Investors.

 

(ii)              
Subject to Section 2.11, if the Institutional Investors elect by written request to the Company, a Shelf Take-Down
shall be in the form of an Underwritten Offering (an “Underwritten Shelf Take-Down Notice”) and the Company
shall amend or supplement the Shelf Registration Statement for such purpose as soon as practicable. The Institutional Investors
shall have the right to select the managing underwriter or underwriters to administer such offering. The provisions of Section 2.01(f)
shall apply to any Underwritten Offering pursuant to this Section 2.02(e).

 

(iii)            
If the plan of distribution set forth in any Underwritten Shelf Take-Down Notice includes a customary “road show”
(including an “electronic road show”) or other marketing effort, which may be conducted confidentially, by the
Company and the underwriters over a period expected to exceed forty-eight (48) hours (a “Marketed Underwritten
Shelf Take-Down”), promptly upon delivery of such Underwritten Shelf Take-Down Notice (but in no event more than three (3)
Business Days thereafter), the Company shall promptly deliver a written notice (a “Marketed Underwritten Shelf Take-Down
Notice”) of such Marketed Underwritten Shelf Take-Down to all Shelf Holders (other than the Institutional Investors),
and the Company shall include in such Marketed Underwritten Shelf Take-Down all such Registrable Securities of such Shelf Holders
that are Registered on such Shelf Registration Statement for which the Company has received written requests, which requests must
specify the aggregate amount of such Registrable Securities of such Holder to be offered and sold pursuant to such Marketed Underwritten
Shelf Take-Down, for inclusion therein within three (3) Business Days after the date that such Marketed Underwritten Shelf
Take-Down Notice has been delivered.

 

    12

     

    

 

Section 2.03.                
Piggyback Registration.

 

(a)               
Participation. If the Company at any time proposes to file a Registration Statement with respect to any Company Public
Sale (other than (i) a Registration Statement proposed to be filed in connection with the IPO, (ii) a Registration under
Section 2.01 or Section 2.02, it being understood that this clause (ii) does not limit the rights of Holders
to make written requests pursuant to Sections 2.01 or 2.02 or otherwise limit the applicability thereof, (iii) a
Registration Statement on Form S-4 or Form S-8, (iv) a registration of securities solely relating to an offering
and sale to employees, directors or consultants of the Company or its Subsidiaries pursuant to any employee stock plan or other
employee benefit plan arrangement, (v) a registration not otherwise covered by clause (iii) above pursuant to which the Company
is offering to exchange its own securities for other securities, (vi) a Registration Statement relating solely to dividend
reinvestment or similar plans or (vii) a Shelf Registration Statement pursuant to which only the initial purchasers and subsequent
transferees of debt securities of the Company or any of its Subsidiaries that are convertible or exchangeable for Company Shares
and that are initially issued pursuant to Rule 144A and/or Regulation S (or any successor provisions) of the Securities
Act may resell such notes and sell the Company Shares into which such notes may be converted or exchanged), then, (A) as soon
as practicable (but in no event less than thirty (30) days prior to the proposed date of filing of such Registration Statement),
the Company shall give written notice of such proposed filing to the Institutional Investor, and such notice shall offer each Institutional
Investor the opportunity to Register under such Registration Statement such number of Registrable Securities as such Institutional
Investor may request in writing delivered to the Company within ten (10) days of delivery of such written notice by the Company,
and (B) subject to Section 2.03(c), as soon as practicable after the expiration of such ten (10) -day period
(but in no event less than fifteen (15) days prior to the proposed date of filing of such Registration Statement), the Company
shall give written notice of such proposed filing to the Holders (other than the Institutional Investor), and such notice shall
offer each such Holder the opportunity to Register under such Registration Statement such number of Registrable Securities as such
Holder may request in writing within ten (10) days of delivery of such written notice by the Company. Subject to Sections 2.03(b)
and (c), the Company shall include in such Registration Statement all such Registrable Securities that are requested by
Holders to be included therein in compliance with the immediately foregoing sentence (a “Piggyback Registration”);
provided, that, if at any time after giving written notice of its intention to Register any equity securities and prior
to the effective date of the Registration Statement filed in connection with such Piggyback Registration, the Company shall determine
for any reason not to Register or to delay Registration of the equity securities covered by such Piggyback Registration, the Company
shall give written notice of such determination to each Holder that had requested to Register its, his or her Registrable Securities
in such Registration Statement and, thereupon, (1) in the case of a determination not to Register, shall be relieved of its
obligation to Register any Registrable Securities in connection with such Registration (but not from its obligation to pay the
Registration Expenses in connection therewith, to the extent payable), without prejudice, however, to the rights of the Institutional
Investors to request that such Registration be effected as a Demand Registration under Section 2.01, and (2) in
the case of a determination to delay Registering, in the absence of a request by the Institutional Investors to request that such
Registration be effected as a Demand Registration under Section 2.01, shall be permitted to delay Registering any Registrable
Securities, for the same period as the delay in Registering the other equity securities covered by such Piggyback Registration.
If the offering pursuant to such Registration Statement is to be underwritten, the Company shall so advise the Holders as a part
of the written notice given pursuant this Section 2.03(a), and each Holder making a request for a Piggyback Registration
pursuant to this Section 2.03(a) must, and the Company shall make such arrangements with the managing underwriter or
underwriters so that each such Holder may, participate in such Underwritten Offering, subject to the conditions of Section 2.03(b)
and (c). If the offering pursuant to such Registration Statement is to be on any other basis, the Company shall so advise
the Holders as part of the written notice given pursuant to this Section 2.03(a), and each Holder making a request
for a Piggyback Registration pursuant to this Section 2.03(a) must, and the Company shall make such arrangements so
that each such Holder may, participate in such offering on such basis, subject to the conditions of Section 2.03(b)
and (c). Each Holder shall be permitted to withdraw all or part of its Registrable Securities from a Piggyback Registration
at any time prior to the effectiveness of such Registration Statement.

 

    13

     

    

 

(b)               
Priority of Piggyback Registration. If the managing underwriter or underwriters of any proposed Underwritten Offering
of Registrable Securities included in a Piggyback Registration informs the Company and the Holders that have requested to participate
in such Piggyback Registration in writing that, in its or their opinion, the number of securities which such Holders and any other
Persons intend to include in such offering exceeds the number which can be sold in such offering without being likely to have a
significant adverse effect on the price, timing or distribution of the securities offered or the market for the securities offered,
then the securities to be included in such Registration shall be (i) first, 100% of the securities that the Company
or (subject to Section 2.07) any Person (other than a Holder) exercising a contractual right to demand Registration,
as the case may be, proposes to sell, (ii) second, and only if all the securities referred to in clause (i) have been
included, the number of Registrable Securities that, in the opinion of such managing underwriter or underwriters, can be sold without
having such adverse effect in such Registration, which such number shall be allocated pro rata among the Holders that have
requested to participate in such Registration based on the relative number of Registrable Securities then held by each such Holder
(provided, that any securities thereby allocated to a Holder that exceed such Holder’s request shall be reallocated
among the remaining requesting Holders in like manner), and (iii) third, and only if all of the Registrable Securities
referred to in clause (ii) have been included in such Registration, any other securities eligible for inclusion in such Registration
that, in the opinion of the managing underwriter or underwriters, can be sold without having such adverse effect in such Registration.

 

(c)               
Restrictions on Non-Institutional Investor Holders. Notwithstanding any provisions contained herein, Holders other
than the Institutional Investors shall not be able to exercise the right to a Piggyback Registration unless at least one Institutional
Investor exercises its rights with respect to such Piggyback Registration.

 

(d)               
No Effect on Demand Registrations. No Registration of Registrable Securities effected pursuant to a request under
this Section 2.03 shall be deemed to have been effected pursuant to Section 2.01 or Section 2.02
or shall relieve the Company of its obligations under Section 2.01 or Section 2.02.

 

Section 2.04.                
Black-out Periods.

 

(a)               
Black-out Periods for Holders. In the event of a Company Public Sale of the Company’s equity securities in
an Underwritten Offering, each of the Holders agrees, if requested by the managing underwriter or underwriters in such Underwritten
Offering (and, with respect to a Company Public Sale other than the IPO, if and only if the Institutional Investors also agree
to such request), not to (1) offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device
that is designed to, or could be expected to, result in the disposition by any Person at any time in the future of) any Company
Shares (including Company Shares that may be deemed to be beneficially owned by the undersigned in accordance with the rules and
regulations of the SEC and Company Shares that may be issued upon exercise of any options or warrants) or Company Share Equivalents
or any other securities of the Company, (2) enter into any swap or other derivatives transaction that transfers to another,
in whole or in part, any of the economic benefits or risks of ownership of Company Shares, Company Share Equivalents or any other
securities of the Company, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Company
Shares or other securities, in cash or otherwise, (3) make any demand for or exercise any right or cause to be filed a Registration
Statement, including any amendments thereto, with respect to the registration of any Company Shares or Company Share Equivalents
or any other securities of the Company or (4) publicly disclose the intention to do any of the foregoing without the prior
written consent of the Company, in each case, during the period commencing on the date of such offering and continuing for not
more than one hundred eighty (180) days (in the event of the IPO) or ninety (90) days (in the event of any other Company
Public Sale) after the date of the underwriting agreement entered into in connection with such IPO or Company Public Sale, to the
extent timely notified in writing by the Company or the managing underwriter or underwriters; provided, that no Holder shall
be subject to any such black-out period of longer duration than that applicable to any Institutional Investor and such restrictions
shall be subject to customary exceptions typically included in underwriter lock-up agreements, to the extent acceptable to the
managing underwriter or underwriters. If requested by the managing underwriter or underwriters of any such Company Public Sale
(and, with respect to any such Company Public Sale other than the IPO, if and only if the Institutional Investors agree to such
request and enters into such separate agreement), the Holders shall execute a separate agreement to the foregoing effect. The Company
may impose stop-transfer instructions with respect to the Company Shares or Company Share Equivalents (or other securities) subject
to the foregoing restriction until the end of the period referenced above.

 

    14

     

    

 

(b)               
Black-out Period for the Company and Others. In the case of an offering of Registrable Securities pursuant to Section 2.01
or 2.02 that is a Marketed Underwritten Offering, the Company and each of the Holders agree, if requested by the managing
underwriter or underwriters with respect to such Marketed Underwritten Offering and only to the extent the Institutional Investors
also agree, not to (1) offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that
is designed to, or could be expected to, result in the disposition by any Person at any time in the future of) any Company Shares
(including Company Shares that may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations
of the SEC and Company Shares that may be issued upon exercise of any options or warrants) or Company Share Equivalents or any
other securities of the Company, (2) enter into any swap or other derivatives transaction that transfers to another, in whole
or in part, any of the economic benefits or risks of ownership of Company Shares, whether any such transaction described in clause
(1) or (2) above is to be settled by delivery of Company Shares or other securities, in cash or otherwise, (3) make any demand
for or exercise any right or cause to be filed a Registration Statement, including any amendments thereto, with respect to the
registration of any Company Shares or Company Share Equivalents or any other securities of the Company or (4) publicly disclose
the intention to do any of the foregoing without the prior written consent of the Company, in each case, during the period commencing
on the date of such offering and continuing for not more than ninety (90) days (or such lesser period as may be agreed by
the managing underwriter or underwriters) after the date of the underwriting agreement entered into in connection with such Marketed
Underwritten Offering, to the extent timely notified in writing by an Institutional Investor or the managing underwriter or underwriters,
as the case may be; provided, that no Holder shall be subject to any such black-out period of longer duration than that
applicable to any Institutional Investor and such restrictions shall be subject to customary exceptions typically included in underwriter
lock-up agreements, to the extent acceptable to the managing underwriter or underwriters. Notwithstanding the foregoing, the Company
may effect a public sale or distribution of securities of the type described above and during the periods described above if such
sale or distribution is made pursuant to Registrations on Form S-4 or Form S-8 or as part of any Registration of securities
for offering and sale to employees, directors or consultants of the Company and its Subsidiaries pursuant to any employee stock
plan or other employee benefit plan arrangement. The Company agrees to use its reasonable best efforts to obtain from each of its
directors and officers and each other holder of restricted securities of the Company which securities are the same as or similar
to the Registrable Securities being Registered, or any restricted securities convertible into or exchangeable or exercisable for
any of such securities, an agreement not to effect any public sale or distribution of such securities during any such period referred
to in this paragraph, except as part of any such Registration, if permitted. Without limiting the foregoing (but subject to Section 2.07),
if after the date hereof the Company or any of its Subsidiaries grants any Person (other than a Holder) any rights to demand or
participate in a Registration, the Company shall, and shall cause its Subsidiaries to, provide that the agreement with respect
thereto shall include such Person’s agreement to comply with any black-out period required by this Section 2.04(b)
as if it were a Holder hereunder. If requested by the managing underwriter or underwriters of any such Marketed Underwritten
Offering (and if and only if the Institutional Investors agree to such request and enters into such separate agreement), the Holders
shall execute a separate agreement to the foregoing effect. Subject to the provisions of this Agreement, the Company shall be responsible
for negotiating all lock-up agreements with the managing underwriters and the Holders agree to execute the form so negotiated in
accordance with the terms of this Agreement. The Company may impose stop-transfer instructions with respect to the Company Shares
(or other securities) subject to the foregoing restriction until the end of the period referenced above.

 

    15

     

    

 

 

 

(c)               
Notwithstanding anything contained to the contrary, nothing contained in this Section 2.04 shall apply to any
Excluded Holder, except in connection with an IPO.

 

Section 2.05.                
Registration Procedures.

 

(a)               
In connection with the Company’s Registration obligations under Sections 2.01, 2.02, and 2.03
and subject to the applicable terms and conditions set forth therein, the Company shall use its reasonable best efforts to
effect such Registration to permit the sale of such Registrable Securities in accordance with the intended method or methods of
distribution thereof as expeditiously as reasonably practicable, and in connection therewith the Company shall:

 

(i)                
prepare the required Registration Statement including all exhibits and financial statements required under the Securities
Act to be filed therewith, and before filing a Registration Statement, Prospectus or any Issuer Free Writing Prospectus, or any
amendments or supplements thereto, (x) furnish to the underwriters, if any, and the Institutional Investors, if applicable,
copies of all documents prepared to be filed, which documents shall be subject to the review of such underwriters and the Institutional
Investors and their respective counsel and (y) except in the case of a Registration under Section 2.03, not file
any Registration Statement or Prospectus or amendments or supplements thereto to which the Institutional Investors or the underwriters,
if any, shall reasonably object;

 

(ii)               
as promptly as practicable and in accordance with the other provisions of this Agreement, file with the SEC a Registration
Statement relating to the Registrable Securities including all exhibits and financial statements required by the SEC to be filed
therewith, and use its reasonable best efforts to cause such Registration Statement to become effective under the Securities Act
as soon as practicable;

 

(iii)              
prepare and file with the SEC such pre- and post-effective amendments to such Registration Statement, supplements to the
Prospectus and such amendments or supplements to any Issuer Free Writing Prospectus as may be (x) reasonably requested by
the Institutional Investors, (y) reasonably requested by any other Participating Holder (to the extent such request relates
to information relating to such Participating Holder), or (z) necessary to keep such Registration effective for the period
of time required by this Agreement, and comply with provisions of the applicable securities laws with respect to the sale or other
disposition of all securities covered by such Registration Statement during such period in accordance with the intended method
or methods of disposition by the sellers thereof set forth in such Registration Statement;

 

(iv)             
promptly notify the Participating Holders and the managing underwriter or underwriters, if any, and (if requested) confirm
such advice in writing and provide copies of the relevant documents, as soon as reasonably practicable after notice thereof is
received by the Company (A) when the applicable Registration Statement or any amendment thereto has been filed or becomes
effective, and when the applicable Prospectus or Issuer Free Writing Prospectus or any amendment or supplement thereto has been
filed, (B) of any written comments by the SEC or any request by the SEC or any other federal or state governmental authority
for amendments or supplements to such Registration Statement, Prospectus or Issuer Free Writing Prospectus or for additional information,
(C) of the issuance by the SEC of any stop order suspending the effectiveness of such Registration Statement or any order
by the SEC or any other regulatory authority preventing or suspending the use of any preliminary or final Prospectus or any Issuer
Free Writing Prospectus or the initiation or threatening of any proceedings for such purposes, (D) if, at any time, the representations
and warranties of the Company in any applicable underwriting agreement cease to be true and correct in all material respects,
(E) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable
Securities for offering or sale in any jurisdiction and (F) of the receipt by the Company of any notification with respect
to the initiation or threatening of any proceeding for the suspension of the qualification of the Registrable Securities for offering
or sale in any jurisdiction;

 

    16

     

    

 

(v)               
promptly notify the Participating Holders and the managing underwriter or underwriters, if any, when the Company becomes
aware of the happening of any event as a result of which the applicable Registration Statement, the Prospectus included in such
Registration Statement (as then in effect) or any Issuer Free Writing Prospectus contains any untrue statement of a material fact
or omits to state a material fact necessary to make the statements therein (in the case of such Prospectus, any preliminary Prospectus
or any Issuer Free Writing Prospectus, in light of the circumstances under which they were made) not misleading, when any Issuer
Free Writing Prospectus includes information that may conflict with the information contained in the Registration Statement, or,
if for any other reason it shall be necessary during such time period to amend or supplement such Registration Statement, Prospectus
or Issuer Free Writing Prospectus in order to comply with the Securities Act and, in either case as promptly as reasonably practicable
thereafter, prepare and file with the SEC, and furnish without charge to the Participating Holders and the managing underwriter
or underwriters, if any, an amendment or supplement to such Registration Statement, Prospectus or Issuer Free Writing Prospectus
which shall correct such misstatement or omission or effect such compliance;

 

(vi)             
use its reasonable best efforts to prevent, or obtain the withdrawal of, any stop order or other order suspending the use
of any preliminary or final Prospectus or any Issuer Free Writing Prospectus;

 

(vii)             
promptly incorporate in a Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment to the applicable
Registration Statement such information as the managing underwriter or underwriters and the Institutional Investors (to the extent
the Institutional Investors are participating in such Registration) agree should be included therein relating to the plan of distribution
with respect to such Registrable Securities, and make all required filings of such Prospectus supplement, Issuer Free Writing
Prospectus or post-effective amendment as soon as reasonably practicable after being notified of the matters to be incorporated
in such Prospectus supplement, Issuer Free Writing Prospectus or post-effective amendment;

 

(viii)            
furnish to each Participating Holder and each underwriter, if any, without charge, as many conformed copies as such Participating
Holder or underwriter may reasonably request of the applicable Registration Statement and any amendment or post-effective amendment
thereto, including financial statements and schedules, all documents incorporated therein by reference and all exhibits (including
those incorporated by reference);

 

    17

     

    

 

(ix)              
deliver to each Participating Holder and each underwriter, if any, without charge, as many copies of the applicable Prospectus
(including each preliminary Prospectus), any Issuer Free Writing Prospectus and any amendment or supplement thereto as such Participating
Holder or underwriter may reasonably request (it being understood that the Company consents to the use of such Prospectus, any
Issuer Free Writing Prospectus and any amendment or supplement thereto by such Participating Holder and the underwriters, if any,
in connection with the offering and sale of the Registrable Securities thereby) and such other documents as such Participating
Holder or underwriter may reasonably request in order to facilitate the disposition of the Registrable Securities by such Participating
Holder or underwriter;

 

(x)               
on or prior to the date on which the applicable Registration Statement is declared effective, use its reasonable best efforts
to register or qualify, and cooperate with the Participating Holders, the managing underwriter or underwriters, if any, and their
respective counsel, in connection with the registration or qualification of such Registrable Securities for offer and sale under
the securities or “Blue Sky” laws of each state and other jurisdiction of the United States as any Participating Holder
or managing underwriter or underwriters, if any, or their respective counsel reasonably request in writing and do any and all
other acts or things reasonably necessary or advisable to keep such registration or qualification in effect for such period as
required by Section 2.02(b), provided, that the Company shall not be required to qualify generally to do business
in any jurisdiction where it is not then so qualified or to take any action which would subject it to taxation or general service
of process in any such jurisdiction where it is not then so subject;

 

(xi)              
cooperate with the Participating Holders and the managing underwriter or underwriters, if any, to facilitate the timely
preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends,
and enable such Registrable Securities to be in such denominations and registered in such names as the managing underwriters may
request at least two (2) Business Days prior to any sale of Registrable Securities to the underwriters;

 

(xii)             
use its reasonable best efforts to cause the Registrable Securities covered by the applicable Registration Statement to
be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or
sellers thereof or the underwriter or underwriters, if any, to consummate the disposition of such Registrable Securities;

 

(xiii)            
not later than the effective date of the applicable Registration Statement, provide a CUSIP number for all Registrable
Securities and provide the applicable transfer agent with printed certificates for the Registrable Securities which are in a form
eligible for deposit with The Depository Trust Company or any other required depository;

 

(xiv)            
make such representations and warranties to the Participating Holders and the underwriters or agents, if any, in form,
substance and scope as are customarily made by issuers in secondary underwritten public offerings;

 

(xv)              enter
into such customary agreements (including underwriting and indemnification agreements) and take all such other actions as the
Institutional Investors or the managing underwriter or underwriters, if any, reasonably request in order to expedite or facilitate
the registration and disposition of such Registrable Securities;

 

(xvi)            
obtain for delivery to the Participating Holders and to the underwriter or underwriters, if any, an opinion or opinions
from counsel for the Company dated the effective date of the Registration Statement or, in the event of an Underwritten Offering,
the date of the closing under the underwriting agreement, in customary form, scope and substance, which opinions shall be reasonably
satisfactory to such Participating Holders or underwriters, as the case may be, and their respective counsel;

 

    18

     

    

 

(xvii)           
in the case of an Underwritten Offering, obtain for delivery to the Company and the managing underwriter or underwriters,
with copies to the Participating Holders, a cold comfort letter from the Company’s independent certified public accountants
in customary form and covering such matters of the type customarily covered by cold comfort letters as the managing underwriter
or underwriters reasonably request, dated the date of execution of the underwriting agreement and brought down to the closing
under the underwriting agreement;

 

(xviii)          
cooperate with each Participating Holder and each underwriter, if any, participating in the disposition of such Registrable
Securities and their respective counsel in connection with any filings required to be made with the FINRA;

 

(xix)            
use its reasonable best efforts to comply with all applicable securities laws and make available to its security holders,
as soon as reasonably practicable, an earnings statement satisfying the provisions of section 11(a) of the Securities Act
and the rules and regulations promulgated thereunder;

 

(xx)             
provide and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable
Registration Statement from and after a date not later than the effective date of such Registration Statement;

 

(xxi)             
use its reasonable best efforts to cause all Registrable Securities covered by the applicable Registration Statement to
be listed on each securities exchange on which any of the Company Shares are then listed or quoted and on each inter-dealer quotation
system on which any of the Company Shares are then quoted;

 

(xxii)            
make available upon reasonable notice at reasonable times and for reasonable periods for inspection by the Institutional
Investors, by any underwriter participating in any disposition to be effected pursuant to such Registration Statement and by any
attorney, accountant or other agent retained by such Institutional Investors or any such underwriter, all pertinent financial
and other records, pertinent corporate documents and properties of the Company, and cause all of the Company’s officers,
directors and employees and the independent public accountants who have certified its financial statements to make themselves
available to discuss the business of the Company and to supply all information reasonably requested by any such Person in connection
with such Registration Statement as shall be necessary to enable them to exercise their due diligence responsibility; provided,
that any such Person gaining access to information regarding the Company pursuant to this Section 2.05(a)(xii) shall
agree to hold in strict confidence and shall not make any disclosure or use any information regarding the Company that the Company
determines in good faith to be confidential, and of which determination such Person is notified, unless (w) the release of
such information is requested or required by law or by deposition, interrogatory, requests for information or documents by a governmental
entity, subpoena or similar process, (x) such information is or becomes publicly known other than through a breach of this
or any other agreement of which such Person has actual knowledge, (y) such information is or becomes available to such Person
on a non-confidential basis from a source other than the Company or (z) such information is independently developed by such
Person;

 

    19

     

    

 

(xxiii)           
in the case of an Underwritten Offering, cause the senior executive officers of the Company to participate in the customary
 “road show” presentations that may be reasonably requested by the managing underwriter or underwriters in any such
Underwritten Offering and otherwise to facilitate, cooperate with, and participate in each proposed offering contemplated herein
and customary selling efforts related thereto; and

 

(xxiv)          
otherwise comply in all material respects with all applicable rules and regulations of the SEC in connection with any Registration
Statement and the disposition of all Registrable Securities covered by such Registration Statement.

 

(b)              
The Company may require each Participating Holder to furnish to the Company such information regarding the distribution
of such securities and such other information relating to such Participating Holder and its ownership of Registrable Securities
as the Company may from time to time reasonably request in writing. Each Participating Holder agrees to furnish such information
to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of
this Agreement.

 

(c)               
Each Participating Holder agrees that, upon delivery of any notice by the Company of the happening of any event of the
kind described in Section 2.05(a)(iv)(C), (D), or (E) or Section 2.05(a)(v), such Participating
Holder will forthwith discontinue disposition of Registrable Securities pursuant to such Registration Statement until (i) such
Participating Holder’s receipt of the copies of the supplemented or amended Prospectus or Issuer Free Writing Prospectus
contemplated by Section 2.05(a)(v), (ii) such Participating Holder is advised in writing by the Company that
the use of the Prospectus or Issuer Free Writing Prospectus, as the case may be, may be resumed, (iii) such Participating
Holder is advised in writing by the Company of the termination, expiration or cessation of such order or suspension referenced
in Section 2.05(a)(iv)(C) or (E) or (iv) such Participating Holder is advised in writing by the
Company that the representations and warranties of the Company in such applicable underwriting agreement are true and correct
in all material respects. If so directed by the Company, such Participating Holder shall deliver to the Company (at the Company’s
expense) all copies, other than permanent file copies then in such Participating Holder’s possession, of the Prospectus
or any Issuer Free Writing Prospectus covering such Registrable Securities current at the time of delivery of such notice. In
the event the Company shall give any such notice, the period during which the applicable Registration Statement is required to
be maintained effective shall be extended by the number of days during the period from and including the date of the giving of
such notice to and including the date when each seller of Registrable Securities covered by such Registration Statement either
receives the copies of the supplemented or amended Prospectus or Issuer Free Writing Prospectus contemplated by Section 2.05(a)(v)
or is advised in writing by the Company that the use of the Prospectus or Issuer Free Writing Prospectus may be resumed.

 

Section 2.06.                
Underwritten Offerings.

 

(a)               
Demand and Shelf Registrations. If requested by the underwriters for any Underwritten Offering requested by the
Institutional Investors pursuant to a Registration under Section 2.01 or Section 2.02, as applicable,
the Company shall enter into an underwriting agreement with such underwriters for such offering, such agreement to be reasonably
satisfactory in substance and form to the Company, the Institutional Investors and the underwriters, and to contain such representations
and warranties by the Company and such other terms as are generally prevailing in agreements of that type, including indemnities
no less favorable to the recipient thereof than those provided in Section 2.09. The Institutional Investors shall
cooperate with the Company in the negotiation of such underwriting agreement and shall give consideration to the reasonable suggestions
of the Company regarding the form thereof. The Participating Holders shall be parties to such underwriting agreement, which underwriting
agreement shall (i) contain such representations and warranties by, and the other agreements on the part of, the Company
to and for the benefit of such Participating Holders as are customarily made by issuers to selling stockholders in secondary underwritten
public offerings and (ii) provide that any or all of the conditions precedent to the obligations of such underwriters under
such underwriting agreement also shall be conditions precedent to the obligations of such Participating Holders. Any such Participating
Holder shall not be required to make any representations or warranties to or agreements with the Company or the underwriters in
connection with such underwriting agreement other than representations, warranties or agreements regarding such Participating
Holder, such Participating Holder’s title to the Registrable Securities, such Participating Holder’s authority to
sell the Registrable Securities, such Participating Holder’s intended method of distribution, absence of liens with respect
to the Registrable Securities, enforceability of the applicable underwriting agreement as against such Participating Holder, receipt
of all consents and approvals with respect to the entry into such underwriting agreement and the sale of such Registrable Securities
and any other representations required to be made by such Participating Holder under applicable law, rule or regulation, and the
aggregate amount of the liability of such Participating Holder in connection with such underwriting agreement shall not exceed
such Participating Holder’s net proceeds from such Underwritten Offering.

 

    20

     

    

 

(b)               
Piggyback Registrations. If the Company proposes to register any of its securities under the Securities Act as contemplated
by Section 2.03 and such securities are to be distributed in an Underwritten Offering through one or more underwriters,
the Company shall, if requested by any Holder pursuant to Section 2.03 and subject to the provisions of Section 2.03(b)
and (c), use its reasonable best efforts to arrange for such underwriters to include on the same terms and conditions that
apply to the other sellers in such Registration all the Registrable Securities to be offered and sold by such Holder among the
securities of the Company to be distributed by such underwriters in such Registration. The Participating Holders shall be parties
to the underwriting agreement between the Company and such underwriters, which underwriting agreement shall (i) contain such
representations and warranties by, and the other agreements on the part of, the Company to and for the benefit of such Participating
Holders as are customarily made by issuers to selling stockholders in secondary underwritten public offerings and (ii) provide
that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement also shall
be conditions precedent to the obligations of such Participating Holders. Any such Participating Holder shall not be required
to make any representations or warranties to, or agreements with the Company or the underwriters in connection with such underwriting
agreement other than representations, warranties or agreements regarding such Participating Holder, such Participating Holder’s
title to the Registrable Securities, such Participating Holder’s authority to sell the Registrable Securities, such Holder’s
intended method of distribution, absence of liens with respect to the Registrable Securities, enforceability of the applicable
underwriting agreement as against such Participating Holder, receipt of all consents and approvals with respect to the entry into
such underwriting agreement and the sale of such Registrable Securities or any other representations required to be made by such
Participating Holder under applicable law, rule or regulation, and the aggregate amount of the liability of such Participating
Holder in connection with such underwriting agreement shall not exceed such Participating Holder’s net proceeds from such
Underwritten Offering.

 

(c)               
Participation in Underwritten Registrations. Subject to the provisions of Sections 2.06(a) and 2.06(b)
above, no Person may participate in any Underwritten Offering hereunder unless such Person (i) agrees to sell such Person’s
securities on the basis provided in any underwriting arrangements approved by the Persons entitled to approve such arrangements
and (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents
required under the terms of such underwriting arrangements.

 

    21

     

    

 

(d)               
Price and Underwriting Discounts. In the case of an Underwritten Offering under Section 2.01 or Section 2.02,
the price, underwriting discount and other financial terms for the Registrable Securities shall be determined by the Institutional
Investors so long as all Registrable Securities are subject to the same financial terms.

 

Section 2.07.                
No Inconsistent Agreements; Additional Rights. The Company is not currently
a party to, and shall not hereafter enter into without the prior written consent of the Institutional Investors, any agreement
with respect to its securities that is inconsistent with the rights granted to the Holders by this Agreement, including allowing
any other holder or prospective holder of any securities of the Company (a) registration rights in the nature or substantially
in the nature of those set forth in Section 2.01, Section 2.02 or Section 2.03 that would
have priority over the Registrable Securities with respect to the inclusion of such securities in any Registration (except to
the extent such registration rights are solely related to registrations of the type contemplated by Section 2.03(a)(iii)
and (iv)) or (b) demand registration rights in the nature or substantially in the nature of those set forth in Section 2.01
or Section 2.02 that are exercisable prior to such time as the Institutional Investors and the Holders can first
exercise their rights under Section 2.01 or Section 2.02, as applicable.

 

Section 2.08.                
Registration Expenses. All expenses incident to the Company’s performance
of or compliance with this Agreement shall be paid by the Company, including (i) all registration and filing fees, and any
other fees and expenses associated with filings required to be made with the SEC, FINRA and if applicable, the fees and expenses
of any “qualified independent underwriter,” as such term is defined in FINRA Rule 5121 (or any successor provision),
and of its counsel, (ii) all fees and expenses in connection with compliance with any securities or “Blue Sky”
laws (including fees and disbursements of counsel for the underwriters in connection with “Blue Sky” qualifications
of the Registrable Securities), (iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery
expenses (including expenses of printing certificates for the Registrable Securities in a form eligible for deposit with The Depository
Trust Company or any other required depositories and of printing Prospectuses and Issuer Free Writing Prospectuses), (iv) all
fees and disbursements of counsel for the Company and of all independent certified public accountants of the Company (including
the expenses of any special audit and cold comfort letters required by or incident to such performance), (v) Securities Act
liability insurance or similar insurance if the Company so desires or the underwriters so require in accordance with then-customary
underwriting practice, (vi) all fees and expenses incurred in connection with the listing of Registrable Securities on any
securities exchange or quotation of the Registrable Securities on any inter-dealer quotation system, (vii) all applicable
rating agency fees with respect to the Registrable Securities, (viii) all reasonable fees and disbursements of one legal
counsel and one accounting firm as selected by the holders of a majority of the Registrable Securities included in such Registration,
(ix) any reasonable fees and disbursements of underwriters customarily paid by issuers or sellers of securities, (x) all
fees and expenses of any special experts or other Persons retained by the Company in connection with any Registration, (xi) all
of the Company’s internal expenses (including all salaries and expenses of its officers and employees performing legal or
accounting duties), (xii) all expenses related to the “road-show” for any Underwritten Offering, including
all travel, meals and lodging and (xiii) any other fees and disbursements customarily paid by the issuers of securities. All such
expenses are referred to herein as “Registration Expenses.” The Company shall not be required to pay any underwriting
discounts and commissions and transfer taxes, if any, attributable to the sale of Registrable Securities. In connection with each
Registration or offering made pursuant to this Agreement, the Company shall pay (i) the reasonable fees and expenses of the
Institutional Investors’ counsel and (ii) the reasonable fees and expenses of one counsel to the other Holders (not
including the Institutional Investors), which counsel shall be designated by other Holders holding a majority of the Registrable
Securities included in such Registration and may (but is not required to) be the same counsel for the Institutional Investors.

 

    22

     

    

 

Section 2.09.                
Indemnification.

 

(a)               
Indemnification by the Company. The Company agrees to indemnify and hold harmless, to the full extent permitted
by law, each of the Holders, each of their respective direct or indirect partners, members, managers or shareholders and each
of such partner’s, member’s or shareholder’s partners, members, managers or shareholders and, with respect to
all of the foregoing Persons, each of their respective Affiliates, employees, directors, officers, trustees or agents and each
Person who controls (within the meaning of the Securities Act or the Exchange Act) such Persons and each of their respective Representatives
from and against any and all losses, penalties, judgments, suits, costs, claims, damages, liabilities and expenses, joint or several
(including reasonable costs of preparation and investigation and legal expenses) (each, a “Loss” and collectively, “Losses”)
arising out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any Registration
Statement under which such Registrable Securities were Registered under the Securities Act (including any final, preliminary or
summary Prospectus contained therein or any amendment or supplement thereto or any documents incorporated by reference therein),
any Issuer Free Writing Prospectus or amendment or supplement thereto, or any other disclosure document produced by or on behalf
of the Company or any of its Subsidiaries including reports and other documents filed under the Exchange Act, (ii) any omission
or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein
(in the case of a Prospectus, preliminary Prospectus or Issuer Free Writing Prospectus, in light of the circumstances under which
they were made) not misleading, (iii) any violation or alleged violation by the Company of any federal, state or common law
rule or regulation applicable to the Company or any of its Subsidiaries in connection with any such registration, qualification,
compliance or sale of Registrable Securities, (iv) any failure to register or qualify Registrable Securities in any state
where the Company or its agents have affirmatively undertaken or agreed in writing that the Company (the undertaking of any underwriter
being attributed to the Company) will undertake such registration or qualification on behalf of the Holders of such Registrable
Securities (provided, that, in such instance, the Company shall not be so liable if it has undertaken its reasonable best
efforts to so register or qualify such Registrable Securities) or (v) any actions or inactions or proceedings in respect
of the foregoing whether or not such indemnified party is a party thereto, and the Company will reimburse, as incurred, each such
Holder and each of their respective direct or indirect partners, members or shareholders and each of such partner’s, member’s
or shareholder’s partners members or shareholders and, with respect to all of the foregoing Persons, each of their respective
Affiliates, employees, directors, officers, trustees or agents and controlling Persons and each of their respective Representatives,
for any legal and any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage,
liability or action; provided, that the Company shall not be liable to any particular indemnified party to the extent that
any such Loss arises out of or is based upon (A) an untrue statement or alleged untrue statement or omission or alleged omission
made in any such Registration Statement or other document in reliance upon and in conformity with written information furnished
to the Company by such indemnified party expressly for use in the preparation thereof or (B) an untrue statement or omission
in a preliminary Prospectus relating to Registrable Securities, if a Prospectus (as then amended or supplemented) that would have
cured the defect was furnished to the indemnified party from whom the Person asserting the claim giving rise to such Loss purchased
Registrable Securities at least five (5) days prior to the written confirmation of the sale of the Registrable Securities
to such Person and a copy of such Prospectus (as amended and supplemented) was not sent or given by or on behalf of such indemnified
party to such Person at or prior to the written confirmation of the sale of the Registrable Securities to such Person. This indemnity
shall be in addition to any liability the Company may otherwise have. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such Holder or any indemnified party and shall survive the transfer of such securities
by such Holder. The Company shall also indemnify underwriters, selling brokers, dealer managers and similar securities industry
professionals participating in the distribution, their officers and directors and each Person who controls such Persons (within
the meaning of the Securities Act and the Exchange Act) to the same extent as provided above with respect to the indemnification
of the indemnified parties.

 

    23

     

    

 

(b)               
Indemnification by the Participating Holders. Each Participating Holder agrees (severally and not jointly) to indemnify
and hold harmless, to the fullest extent permitted by law, the Company, its directors and officers and each Person who controls
the Company (within the meaning of the Securities Act or the Exchange Act), and each other Holder, each of such other Holder’s
respective direct or indirect partners, members, managers or shareholders and each of such partner’s, member’s or
shareholder’s partners, members, managers or shareholders and, with respect to all of the foregoing Persons, each of their
respective Affiliates, employees, directors, officers, trustees or agents and each Person who controls (within the meaning of
the Securities Act or the Exchange Act) such Persons and each of their respective Representatives from and against any Losses
resulting from (i) any untrue statement or alleged untrue statement of a material fact in any Registration Statement under
which such Registrable Securities were Registered under the Securities Act (including any final, preliminary or summary Prospectus
contained therein or any amendment or supplement thereto or any documents incorporated by reference therein) or any Issuer Free
Writing Prospectus or amendment or supplement thereto, or (ii) any omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein (in the case of a Prospectus, preliminary Prospectus
or Issuer Free Writing Prospectus, in light of the circumstances under which they were made) not misleading, in each case to the
extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is
contained in any information furnished in writing by such Holder to the Company specifically for inclusion in such Registration
Statement and has not been corrected in a subsequent writing prior to or concurrently with the sale of the Registrable Securities
to the Person asserting the claim, in each case to the extent, but only to the extent, that such untrue statement (or alleged
untrue statement) or omission (or alleged omission) was made in such Registration Statement, Prospectus, offering circular, Issuer
Free Writing Prospectus or other document, in reliance upon and in conformity with written information furnished to the Company
by such Holder expressly for use therein. In no event shall the liability of such Holder hereunder be greater in amount than the
dollar amount of the net proceeds received by such Holder under the sale of Registrable Securities giving rise to such indemnification
obligation.

 

(c)               
Conduct of Indemnification Proceedings. Any Person entitled to indemnification under this Section 2.09
shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification
(provided, that any delay or failure to so notify the indemnifying party shall relieve the indemnifying party of its obligations
hereunder only to the extent, if at all, that it is actually and materially prejudiced by reason of such delay or failure) and
(ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified
party; provided, that any Person entitled to indemnification hereunder shall have the right to select and employ separate
counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of
such Person unless (A) the indemnifying party has agreed in writing to pay such fees or expenses, (B) the indemnifying
party shall have failed to assume the defense of such claim within a reasonable time after delivery of notice of such claim from
the Person entitled to indemnification hereunder and employ counsel reasonably satisfactory to such Person, (C) the indemnified
party has reasonably concluded (based upon advice of its counsel) that there may be legal defenses available to it or other indemnified
parties that are different from or in addition to those available to the indemnifying party, or (D) in the reasonable judgment
of any such Person (based upon advice of its counsel) a conflict of interest may exist between such Person and the indemnifying
party with respect to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects
to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume
the defense of such claim on behalf of such Person). If the indemnifying party assumes the defense, the indemnifying party shall
not have the right to settle such action, consent to entry of any judgment or enter into any settlement, in each case without
the prior written consent of the indemnified party, unless the entry of such judgment or settlement (i) includes as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of an unconditional release from all liability
in respect to such claim or litigation and (ii) does not include a statement as to or an admission of fault, culpability
or a failure to act by or on behalf of such indemnified party, and provided, that any sums payable in connection with such
settlement are paid in full by the indemnifying party. If such defense is not assumed by the indemnifying party, the indemnifying
party will not be subject to any liability for any settlement made without its prior written consent, but such consent may not
be unreasonably withheld. It is understood that the indemnifying party or parties shall not, except as specifically set forth
in this Section 2.09(c), in connection with any proceeding or related proceedings in the same jurisdiction, be liable
for the reasonable fees, disbursements or other charges of more than one separate firm admitted to practice in such jurisdiction
at any one time unless (x) the employment of more than one counsel has been authorized in writing by the indemnifying party
or parties, (y) an indemnified party has reasonably concluded (based on the advice of counsel) that there may be legal defenses
available to it that are different from or in addition to those available to the other indemnified parties, or (z) a conflict
or potential conflict exists or may exist (based upon advice of counsel to an indemnified party) between such indemnified party
and the other indemnified parties, in each of which cases the indemnifying party shall be obligated to pay the reasonable fees
and expenses of such additional counsel or counsels.

 

    24

     

    

 

(d)               
Contribution. If for any reason the indemnification provided for in paragraphs (a) and (b) of this Section 2.09
is unavailable to an indemnified party or insufficient in respect of any Losses referred to therein, then the indemnifying
party shall contribute to the amount paid or payable by the indemnified party as a result of such Loss in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and the indemnified party or parties on the
other hand in connection with the acts, statements or omissions that resulted in such losses, as well as any other relevant equitable
considerations. In connection with any Registration Statement filed with the SEC by the Company, the relative fault of the indemnifying
party on the one hand and the indemnified party on the other hand shall be determined by reference to, among other things, whether
any untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would
not be just or equitable if contribution pursuant to this Section 2.09(d) were determined by pro rata allocation
or by any other method of allocation that does not take account of the equitable considerations referred to in this Section 2.09(d).
No Person guilty of fraudulent misrepresentation (within the meaning of section 11(f) of the Securities Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation. The amount paid or payable by an indemnified
party as a result of the Losses referred to in Sections 2.09(a) and 2.09(b) shall be deemed to include, subject
to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any such action or claim. Notwithstanding the provisions of this Section 2.09(d), in connection
with any Registration Statement filed by the Company, a Participating Holder shall not be required to contribute any amount in
excess of the dollar amount of the net proceeds received by such Holder under the sale of Registrable Securities giving rise to
such contribution obligation less any amount paid by such Holders pursuant to Section 2.09(b). If indemnification
is available under this Section 2.09, the indemnifying parties shall indemnify each indemnified party to the full
extent provided in Sections 2.09(a) and 2.09(b) hereof without regard to the provisions of this Section 2.09(d).

 

(e)               
No Exclusivity. The remedies provided for in this Section 2.09 are not exclusive and shall not limit
any rights or remedies which may be available to any indemnified party at law or in equity or pursuant to any other agreement.

 

    25

     

    

 

(f)                
Conflicts. Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution
contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with
the foregoing provisions in this Section 2.09, the provisions in the underwriting agreement shall control.

 

(g)               
Survival. The indemnities provided in this Section 2.09 shall survive the transfer of any Registrable
Securities by such Holder.

 

Section 2.10.                
Rules 144 and 144A and Regulation S. The Company covenants that it
will file the reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted
by the SEC thereunder (or, if the Company is not required to file such reports, it will, upon the reasonable request of the Institutional
Investors, make publicly available such necessary information for so long as necessary to permit sales pursuant to Rules 144,
144A or Regulation S under the Securities Act), and it will take such further action as the Institutional Investors may reasonably
request, all to the extent required from time to time to enable the Holders, following the IPO, to sell Registrable Securities
without Registration under the Securities Act within the limitation of the exemptions provided by (i) Rules 144, 144A
or Regulation S under the Securities Act, as such Rules may be amended from time to time, or (ii) any similar rule
or regulation hereafter adopted by the SEC. Upon the reasonable request of a Holder, the Company will deliver to such Holder a
written statement as to whether it has complied with such requirements and, if not, the specifics thereof.

 

Section 2.11.                
Limitation on Registrations and Underwritten Offerings. Notwithstanding the
rights and obligations set forth in Sections 2.01 and 2.02, in no event shall the Company be obligated to take
any action to (i) effect more than one Marketed Underwritten Offering in any consecutive 90-day period or (ii) effect
any Underwritten Offering unless the Institutional Investors initiating such Underwritten Offering propose to sell Registrable
Securities in such Underwritten Offering having a reasonably anticipated gross aggregate price (before deduction of underwriter
commissions and offering expenses) of at least $10,000,000.

 

Section 2.12.                
Clear Market. With respect to any Underwritten Offerings of Registrable Securities
by the Institutional Investors pursuant to this Agreement, the Company agrees not to effect (other than pursuant to the Registration
applicable to such Underwritten Offering or pursuant to a Special Registration) any public sale or distribution, or to file any
Registration Statement (other than pursuant to the Registration applicable to such Underwritten Offering or pursuant to a Special
Registration) covering any of its equity securities or any securities convertible into or exchangeable or exercisable for such
securities, during the period not to exceed ten (10) days prior and sixty (60) days following the effective date of
such offering or such longer period up to ninety (90) days as may be requested by the managing underwriter for such Underwritten
Offering. “Special Registration” means the registration of (A) equity securities and/or options or other
rights in respect thereof solely registered on Form S-4 or Form S-8 or (B) shares of equity securities and/or options
or other rights in respect thereof to be offered to directors, employees, consultants, customers, lenders or vendors of the Company
or its Subsidiaries or in connection with dividend reinvestment plans.

 

Section 2.13.                
In-Kind Distributions. If any Institutional Investor, as an Investment Fund
or an Affiliate of an Investment Fund, seeks to effectuate an in-kind distribution of all or part of its Company Shares to its
direct or indirect equityholders, the Company will reasonably cooperate with and assist such Institutional Investor, such equityholders
and the Company’s transfer agent to facilitate such in-kind distribution in the manner reasonably requested by such Institutional
Investor (including the delivery of instruction letters by the Company or its counsel to the Company’s transfer agent, the
delivery of customary legal opinions by counsel to the Company and the delivery of Company Shares without restrictive legends,
to the extent no longer applicable) and any such equityholder shall, with its consent and with the consent of such Institutional
Investor, be treated as an Institutional Investor and/or Holder (as determined by such Institutional Investor) for all purposes
of this Agreement, with the same rights, benefits and obligations hereunder as an Institutional Investor and/or Holder, as applicable.

 

    26

     

    

 

Article III

 

MISCELLANEOUS

 

Section 3.01.                
Term. 

 

(a)               
This Agreement shall terminate with respect to any Holder (i) with the prior written consent of the Institutional
Investors in connection with the consummation of a Change of Control, (ii) for those Holders (other than the Institutional
Investors) that beneficially own less than five percent (5%) of the Company’s outstanding Company Shares, if all of
the Registrable Securities then owned by such Holder could be sold in any ninety (90)-day period pursuant to Rule 144,
(iii) as to any Holder, if all of the Registrable Securities held by such Holder have been sold or otherwise transferred
in a Registration pursuant to the Securities Act or pursuant to an exemption therefrom, or (iv) with respect to any Holder
that is an officer, director, employee or consultant of the Company or any of its Subsidiaries on the date that is ninety (90)
days after the date on which such Holder ceases to be an employee, director or consultant (as applicable) of the Company and its
Subsidiaries.

 

(b)               
Notwithstanding the foregoing, the provisions of Sections 2.09, 2.10 and 2.13 and all of this
Article III shall survive any such termination. Upon the written request of the Company, each Holder agrees to promptly
deliver a certificate to the Company setting forth the number of Registrable Securities then beneficially owned by such Holder.

 

Section 3.02.                
Injunctive Relief. It is hereby agreed and acknowledged that it will be impossible
to measure in money the damage that would be suffered if the parties fail to comply with any of the obligations herein imposed
on them and that in the event of any such failure, an aggrieved Person will be irreparably damaged and will not have an adequate
remedy at law. Any such Person shall, therefore, be entitled (in addition to any other remedy to which it may be entitled in law
or in equity) to injunctive relief, including specific performance, to enforce such obligations, and if any action should be brought
in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall raise the defense that there is
an adequate remedy at law.

 

Section 3.03.                
Attorneys’ Fees. In any action or proceeding brought to enforce any provision
of this Agreement or where any provision hereof is validly asserted as a defense, the successful party shall, to the extent permitted
by applicable law, be entitled to recover reasonable attorneys’ fees in addition to any other available remedy.

 

    27

     

    

 

Section 3.04.                
Notices. Unless otherwise specified herein, all notices, consents, approvals,
reports, designations, requests, waivers, elections and other communications authorized or required to be given pursuant to this
Agreement shall be in writing and shall be deemed to have been given (a) when personally delivered, (b) when transmitted
via facsimile to the number set out below or on Schedule A or Schedule B, as applicable, if the sender
receives confirmation of delivery or if the sender on the same or following Business Day sends a confirming copy of such notice
by a recognized delivery service (charges prepaid), (c) the day following the day (except if not a Business Day then the
next Business Day) on which the same has been delivered prepaid to a reputable national air courier service, (d) when transmitted
via email (including via attached pdf document) to the email address set out below or on Schedule A or Schedule B,
as applicable, as applicable, if the sender on the same day sends a confirming copy of such notice by a recognized delivery service
(charges prepaid) or (e) the third Business Day following the day on which the same is sent by certified or registered mail,
postage prepaid, in each case, to the respective parties, as applicable, at the address, facsimile number or email address set
forth below or on Schedule A or Schedule B hereto, as applicable (or such other address, facsimile number
or email address as any Holder may specify by notice to the Company in accordance with this Section 3.04):

 

EQT Avatar Parent L.P.

c/o EQT Partners Inc.

1114 Avenue of the Americas, 45th Floor

New York, NY 10036

		Fax:	[                ]

		Attention:	Eric Liu

		Email:	[                 ]

with a copy (which shall not constitute actual or constructive
notice) to:

 

Simpson Thacher & Bartlett LLP

2475 Hanover Street

Palo Alto, CA 94304

		Fax:	[                ]

Attention: William Brentani

		Email:	[                ]

 

Section 3.05.                
Publicity and Confidentiality. Each of the parties hereto shall keep confidential
this Agreement and the transactions contemplated hereby, and any nonpublic information received pursuant hereto, and shall not
disclose, issue any press release or otherwise make any public statement relating hereto or thereto without the prior written
consent of the Company and the Institutional Investors unless so required by applicable law or any governmental authority; provided,
that no such written consent shall be required (and each party shall be free to release such information) for disclosures (a) to
each party’s partners, members, advisors, employees, agents, accountants, trustee, attorneys, Affiliates and investment
vehicles managed or advised by such party or the partners, members, advisors, employees, agents, accountants, trustee or attorneys
of such Affiliates or managed or advised investment vehicles, in each case so long as such Persons agree to keep such information
confidential, (b) to the extent required by law, rule or regulation or (c) expressly permitted by this Agreement.

 

Section 3.06.                
Amendment. The terms and provisions of this Agreement may only be amended,
modified or waived at any time and from time to time by a writing executed by the Company and the Institutional Investors; provided,
however, that any modification, amendment or waiver of this Agreement that would subject any Holder (other than the Institutional
Investors and any Excluded Holder) to materially adverse disproportionate treatment relative to the other Holders (other than
the Institutional Investors and any Excluded Holder) taking into account and considering the rights of such Holder prior to such
amendment, modification or waiver (each such Holder, an “Impacted Holder”) shall require the agreement
of the Majority Impacted Holders; provided, further, that any modification, amendment or waiver of Section 2.02(c),
Section 2.02(e), Section 2.03, Section 2.04 or Section 3.06 of this Agreement
(or to any defined term used in any such Section of this Agreement) that would materially and adversely affect the rights of any
Holder (other than the Institutional Investors) or any other modification, amendment or waiver of this Agreement that would impose
upon any Holder (other than the Institutional Investors) any additional material obligation or would materially and adversely
affect the rights of any Holder (other than the Institutional Investors) under Section 2.09 of this Agreement shall
require the agreement of the adversely affected Holders (other than the Institutional Investors) holding a majority of the Registrable
Securities held by all such adversely affected Holders (other than the Institutional Investors) as of the applicable date of determination;
provided, further, that notwithstanding the foregoing proviso, the Institutional Investors may waive Section 2.04(a)
or Section 2.04(b) without the consent of any other Holder, provided, further, that, in the event
the Institutional Investors no longer hold any Company Shares, this Agreement may be amended, modified, supplemented, restated,
waived or terminated with the written consent of (a) the Company and (b) the Holders holding a majority of the Company Shares
held by the Holders. No waiver by any party of any of the provisions hereof will be effective unless explicitly set forth in writing
and executed by the party so waiving. Except as provided in the preceding sentence, no action taken pursuant to this Agreement,
including without limitation, any investigation by or on behalf of any party, will be deemed to constitute a waiver by the party
taking such action of compliance with any covenants or agreements contained herein. The waiver by any party hereto of a breach
of any provision of this Agreement will not operate or be construed as a waiver of any subsequent breach.

 

    28

     

    

 

Section 3.07.                
Successors, Assigns and Transferees. 

 

(a)               
The rights and obligations of each party hereto may not be assigned, in whole or in part, without the written consent of
(i) the Company and (ii) the Institutional Investors; provided, however, that notwithstanding the foregoing,
the rights and obligations set forth herein may be assigned, in whole or in part, by any Institutional Investor to any transferee
of Registrable Securities that holds (after giving effect to such transfer) in excess of one percent (1%) of the then-outstanding
Registrable Securities, and such transferee shall, with the consent of the Institutional Investors, be treated as an Institutional
Investor and/or Holder (as determined by the Institutional Investors) for all purposes under this Agreement (each Person to whom
the rights and obligations are assigned in compliance with this Section 3.07 is a “Permitted Assignee”
and all such Persons, collectively, are “Permitted Assignees”); provided, further, that such
transferee shall only be admitted as a party hereunder upon its, his or her execution and delivery of a joinder agreement, in
form and substance acceptable to the Institutional Investors, agreeing to be bound by the terms and conditions of this Agreement
as if such Person were a party hereto (together with any other documents the Institutional Investors determine are necessary to
make such Person a party hereto), whereupon such Person will be treated as an Institutional Investor and/or Holder, as applicable,
for all purposes of this Agreement, with the same rights, benefits and obligations hereunder as an Institutional Investor and/or
Holder, as applicable, with respect to the transferred Registrable Securities (except that if the transferee was a Holder prior
to such transfer, such transferee shall have the same rights, benefits and obligations with respect to such transferred Registrable
Securities as were applicable to Registrable Securities held by such transferee prior to such transfer).

 

(b)               
Nothing herein shall operate to permit a transfer of Registrable Securities otherwise restricted by the Stockholders Agreement
or any other agreement to which any Holder may be a party.

 

Section 3.08.                
Binding Effect. Except as otherwise provided in this Agreement, the terms and
provisions of this Agreement shall be binding on and inure to the benefit of each of the parties hereto and their respective successors.

 

Section 3.09.                
Third Party Beneficiaries. Nothing in this Agreement, express or implied, is
intended or shall be construed to confer upon any Person not a party hereto (other than those Persons entitled to indemnity or
contribution under Section 2.09, each of whom shall be a third party beneficiary thereof) any right, remedy or claim
under or by virtue of this Agreement.

 

Section 3.10.                
Governing Law; Jurisdiction. THIS AGREEMENT SHALL BE GOVERNED AND CONSTRUED
IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO THE CONFLICTS OF LAW PRINCIPLES THEREOF. ANY ACTION OR
PROCEEDING AGAINST THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT MAY BE BROUGHT AND ENFORCED EXCLUSIVELY IN THE COURTS OF
THE STATE OF DELAWARE OR (TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFOR) THE U.S. DISTRICT COURT FOR THE DISTRICT
OF DELAWARE, AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING.

 

    29

     

    

 

Section 3.11.                
Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST
EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY
ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY. EACH OF THE PARTIES
HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT
IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 3.11.

 

Section 3.12.                
Severability. If any provision of this Agreement shall be held to be invalid,
illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected
or impaired thereby.

 

Section 3.13.                
Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall be deemed an original, and all of which shall constitute one and the same agreement.

 

Section 3.14.                
Headings. The heading references herein and in the table of contents hereto
are for convenience purposes only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of
the provisions hereof.

 

Section 3.15.                
Joinder. Any Person that holds Company Shares may, with the prior written consent
of the Institutional Investors, be admitted as a party to this Agreement upon its execution and delivery of a joinder agreement,
in form and substance acceptable to the Institutional Investors, agreeing to be bound by the terms and conditions of this Agreement
as if such Person were a party hereto (together with any other documents the Institutional Investors determine are necessary to
make such Person a party hereto), whereupon such Person will be treated as a Holder for all purposes of this Agreement.

 

Section 3.16.                
Effectiveness. This Agreement shall become effective on the day immediately
preceding the date on which a registration statement on Form 8-A, or any successor form thereto, with respect to the Company Shares
first becomes effective under the Exchange Act. Until such time as this Agreement becomes effective, the Original Registration
Rights Agreement shall remain in full force and effect. This Agreement shall automatically terminate if the Underwriting Agreement
is terminated for any reason prior to the completion of the IPO or the IPO contemplated by the Underwriting Agreement is not consummated
on or before the tenth (10th) Business Day following the date of this Agreement, provided, that Section 3.17
shall survive any such termination.

 

    30

     

    

 

Section 3.17.                
Reinstatement of Original Registration Rights Agreement. The parties hereto
hereby agree that in the event this Agreement becomes effective but is subsequently terminated pursuant to Section 3.16,
the parties shall either reinstate the Original Registration Rights Agreement or execute a registration rights agreement with
terms that are substantially equivalent (to the extent practicable) to, mutatis mutandis, the terms of the Original Registration
Rights Agreement.

 

[Remainder of Page Intentionally Blank]

 

    31

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the day and year first above written.

 

	 	CERTARA, INC.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Signature Page to Amended and Restated Registration
Rights Agreement]

 

     

     

    

 

	 	INSTITUTIONAL INVESTORS:
	 	 
	 	EQT AVATAR PARENT L.P.
	 	 
	 	By:	EQT Avatar Parent GP LLC, its general partner
	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature Page to Amended and Restated
Registration Rights Agreement]

 

     

     

    

 

Schedule A

 

	INSTITUTIONAL
    INVESTOR	FOR
    PURPOSES OF SECTION 3.04,

 WITH A COPY (WHICH SHALL NOT

 CONSTITUTE NOTICE) TO:
	EQT
Avatar Parent L.P.

        c/o EQT Partners Inc.

        1114 Avenue of the Americas, 45th Floor

        New York, NY 10036

        Fax:                    [           ]

        Attention:           Eric
Liu

        Email:                [          ]

         
	Simpson
Thacher & Bartlett LLP

                                                                                                                         2475
Hanover Street

        Palo Alto, CA 94304

        Fax:                  [         ]

        Attention:         William
Brentani

        Email:               [         ]

         

 

     

     

    

 

Schedule B

 

	HOLDER	FOR PURPOSES OF SECTION 3.04,

with a copy (which shall not

constitute notice) to:
	[                           ]	[                           ]
	[                           ]	[                           ]
	[                           ]	 
	[                           ]	 
	[                           ]	[                           ]
	[                           ]	 
	[                           ]	 
	[                           ]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]